НЕТОКСИЧЕСКИЕ ДИЗИНФЕКТАНТЫ СЛИЗИСТЫХ ОБОЛОЧЕК, СОДЕРЖАЩИЕ ИЗОПРОПИЛОВЫЙ СПИРТ, КУНЖУТНОЕ МАСЛО, АЛОЭ И ЛИМОННОЕ МАСЛО

Изобретение относится к фармацевтической промышленности и используется для лечения инфекции для местного нанесения в нос человека. Нетоксическая композиция дезинфектанта слизистой оболочки однородно смешанных компонентов для местного нанесения в нос, включающая изопропиловый спирт, лимонное масло или лимонную мяту, алоэ или производное алоэ, глюконат хлоргексидина, кунжутное масло, взятые в определенном количестве. Композиция дезинфектанта для лечения инфекции для местного нанесения в нос человека, включающая изопропиловый спирт, лимонное масло или лимонную мяту, алоэ или производное алоэ, глюконат хлоргексидина, кунжутное масло, взятые в определенном количестве. Вышеуказанные композиции эффективны для лечения инфекции для местного нанесения в нос человека. 2 н. и 12 з.п. ф-лы.

ЛЕКАРСТВЕННАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ БРОНХИТА И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

Изобретение относится к фармацевтической промышленности, в частности к фармацевтической композиции для лечения бронхита. Фармацевтическая композиция для лечения бронхита содержит порошок SCUTELLARIAE RADIX; эфирное масло, полученное из смеси растений CITRI RETICULATAE PERICARPIUM и CINNAMOMI RAMULUS; сконцентрированный водный экстракт, полученный изтравяного остатка, оставшегося после получения эфирного масла, и смеси растений, состоящей из ATRACTYLODIS MACROCEPHALAE RHIZOMA, PORIA, GLYCYRRHIZAE RADIX ET RHIZOMA, FARFARAE FLOS, FORSYTHIAE FRUCTUS; сконцентрированный этанольный экстракт из PINELLIAE RHIZOMA, PERILLAE FRUCTUS, SINAPIS SEMEN, RAPHANI SEMEN, ASTERIS RADIX ET RHIZOMA, HOUTTUYNIAE HERBA, ARMENIACAE SEMEN AMARUM.Заявленная фармацевтическая композиция эффективна в устранении мокроты, облегчении кашля, ослаблении астмы, а также сопротивлении воспалению, и оказывает хороший лечебный эффект при лечении бронхита. 10 з.п. ф-лы, 15 табл., 12 пр.

КОМБИНАЦИЯ АКТИВНЫХ ИНГРЕДИЕНТОВ МАСЕЛ, СОДЕРЖАЩИХ W3-ЖИРНЫЕ КИСЛОТЫ, С РАСТИТЕЛЬНЫМИ ЭКСТРАКТАМИ, СОДЕРЖАЩИМИ ПОЛИФЕНОЛЫ, И ИХ ПРИМЕНЕНИЕ

... 1. Комбинация активных ингредиентов, включающая, по меньшей мере, одно масло, содержащее W3-жирные кислоты, и, по меньшей мере, один растительный экстракт, содержащий полифенолы, причем растительный экстракт, содержащий полифенолы, представляет собой экстракт из Vitis vinifera. 2. Комбинация активных ингредиентов по п.1, отличающаяся тем, что масло, содержащее W3-жирную кислоту, содержит альфа-линоленовую кислоту. 3. Комбинация активных ингредиентов по п.2, отличающаяся тем, что масло, содержащее W3-жирную кислоту, выбрано из группы, включающей перилловое масло, масло бораго, масло семян вечерней примулы, рыбий жир, льняное масло и масло семян черной смородины. 4. Комбинация активных ингредиентов по любому из пп.1-3, отличающаяся тем, что растительный экстракт, содержащий полифенолы, содержит, по меньшей мере, 15% полифенолов в расчете на вес сухого вещества. 5. Применение комбинации активных ингредиентов по любому из пп.1-4 для лечения, повышения эффективности лечения и для профилактики ...

ПРЕПАРАТ ИЗ МАСЕЛ ДЛЯ КОРРЕКЦИИ СОСТАВА МИКРОБИОТЫ КИШЕЧНИКА В ФОРМЕ КАПСУЛЫ С КИШЕЧНОРАСТВОРИМОЙ ОБОЛОЧКОЙ

Изобретение относится к области химико-фармацевтической, нутрицевтической промышленности и медицины и касается средства, корректирующего нарушения функционирования микробиоты. Препарат для коррекции состава микробиоты кишечника в форме мягкой капсулы, характеризующийся тем, что содержит оболочку, включающую желатин пищевой, глицерин, альгинат натрия, гидроксипропилметилцеллюлозу, стеариновую кислоту и аммония гидроксид, в которую заключено действующее начало в виде комплекса из масла листьев мяты перечной, эфирного масла корневищ имбиря, токоферола или смеси токоферолов, а также масла, выбранного из оливкового масла рафинированного, масла периллы или их смеси, при следующем содержании компонентов в мг на капсулу: желатин пищевой 110-130, глицерин 43-50, гидроксипропилметилцеллюлоза 22,5-27,5, альгинат натрия 4,7-5,3, аммония гидроксид 0,9-1,1, стеариновая кислота 0,3-0,7, эфирное масло корневищ имбиря 10-500, мяты перечной листьев масло 10-500, токоферол или смесь токоферолов 0,04-0,06, ...

ТРАДИЦИОННАЯ КИТАЙСКАЯ ЛЕКАРСТВЕННАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ БРОНХИАЛЬНОЙ АСТМЫ И СПОСОБ ЕЕ ИЗГОТОВЛЕНИЯ

... 1. Композиция традиционного китайского лекарственного средства для лечения бронхиальной астмы, которая изготовлена из следующего состава сырьевых медицинских материалов:40-90 частей травы эфедры (Herba Ephedrae),136-300 частей коры шелковицы (Cortex Mori),146-300 частей дождевого червя (Lumbricus),46-151 частей семян гингко (Semen Ginkgo),46-151 частей цветов мать-и-мачехи (Flos Farfarae),46-151 частей корневища пинеллии (Rhizoma Pinelliae),46-151 частей плодов периллы (Fructus Perillae),146-300 частей корня пиона красного (Radix Paeoniae Rubra),46-151 частей семян абрикоса горького (Semen Armeniacae Amarum),46-151 частей корня шлемника (Radix Scutellariae),46-151 частей периостракума цикады (Periostracum Cicadae),146-300 частей травы гуттуинии (Herba Houttuyniae),146-300 частей корня трихозанта (Radix Trichosanthis) и46-151 частей плодов форзиции (Fructus Forsythiae).2. Композиция по п.1, которая готовится из следующего состава сырьевых медицинских материалов:50-76 частей травы эфедры ...

МАСЛОЖИРОВАЯ КОМПОЗИЦИЯ И СОДЕРЖАЩИЙ ЕЕ ПИЩЕВОЙ ПРОДУКТ ИЛИ НАПИТОК

... 1. Масложировая композиция, включающая: ! по меньшей мере одно растительное масло A, выбранное из льняного масла, масла периллы и масла семян периллы; ! рисового масла; и ! по меньшей мере одного растительного масла В, выбранного из рапсового масла, соевого масла и кукурузного масла, при соотношении растительного масла A, рисового масла и растительного масла В 20-35/15-25/40-65 по весу, ! причем содержание α-линоленовой кислоты, входящей в состав жирных кислот, содержащихся в масложировой композиции, составляет от 15 до 30 вес.%. ! 2. Масложировая композиция, включающая: ! 20-35 вес.%, по меньшей мере одного растительного масла А, выбранного из льняного масла, масла периллы и масла семян периллы; и ! 15-25 вес.% рисового масла, ! причем содержание α-линоленовой кислоты, входящей в состав жирных кислот, содержащихся в масложировой композиции, составляет от 15 до 30 вес.%. ! 3. Масложировая композиция, включающая: ! 30-53 вес.% по меньшей мере одного растительного масла А, выбранного из льняного ...

ВИЦЕНИН 2 И ЕГО АНАЛОГИ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ АНТИСПАЗМАТИЧЕСКОГО И/ИЛИ ПРОКИНЕТИЧЕСКОГО АГЕНТА

... 1. Применение композиции, содержащей в качестве активного ингредиента виценин 2 или его биологически активный аналог, в качестве антиспазматического и/или прокинетического агента.2. Применение по п. 1, где композиция содержит препарат растительного происхождения, содержащий активный ингредиент, или произведена из него.3. Применение по п. 2, где препарат растительного происхождения обогащен активным ингредиентом.4. Применение по п. 3, где препарат растительного происхождения выбран из одного или более растений из группы, состоящей из Anethum, Perilla, Urtica, Passiflora, Camellia, Cayaponia, Cydonia, Colocasia, Desmodium, Hordeum, Origanum, Ocimum, Jatropha, Parkinsonia, Peperomia, Piheranthos, Centaurea, индиго, Bomba, Lychnophera, Asplenium, Chinotto, Citrus, Viola, Trigonella, других видов, принадлежащих к Lamiacea или Labiatae, розмарина, мяты перечной, чабреца, базилика, шалфея, душицы, Lavandula, Nipponanthemum, Abrus, Viola, Santalum, Oryza, Scleropyrum, туласи, Centaurea, Indigofera ...

Arzneimittel zur Behandlung von Erkältungen und Verfahren zu seiner Herstellung

Die vorliegende Erfindung offenbart ein Arzneimittel zur Behandlung von Erkältungen und das Verfahren zu seiner Herstellung. Das Arzneimittel zur Behandlung von Erkältungen umfasst 10 - 20 Gewichtsteile Fructus forsythiae, 10 - 15 Gewichtsteile Perilla-Blätter und 3 - 20 Gewichtsteile Dandelion. Das erfindungsgemäße Arzneimittel zur Behandlung von Erkältungen weist verglichen mit den Arzneimitteln des Standes der Technik andere Komponenten auf und vermag die Nachteile der Arzneimittel des Standes der Technik zu beseitigen.

Oil-and-fat composition, and food or beverage containing the oil-and-fat composition

Combination of an antiallergic agent with muscarinic antagonist and/or dopaminergic agonist for use in preventing/stopping of axial myopia in human

One of the major issues against the use of muscarinic antagonists or dopamine agonist eyedrops for the controlling of eye growth and prevention of myopia is the unacceptable rate of iatrogenic conjunctivitis or dermatitis. This invention relates to the association of those active principles with an antiallergic component. In alternative the ophthalmic use of a molecule that simultaneously has an antimuscarinic and/or dopaminergic action along with an antihistaminic function.

COMPOSITION COMPRISING VICENIN-2 HAVING A BENEFICIAL EFFECT ON NEUROLOGICAL AND/OR COGNITIVE FUNCTION

The invention relates to an active ingredient and/or to a composition having beneficial effect on neurological and cognitive functions.

Stomach-invigorating and digestion-promoting oral solution and preparation method thereof

Health food capsules with efficacy of assisting in reducing blood fat and preparation method thereof

Preparation method and application of biological agent with no drug resistance

Traditional Chinese medicine composition for treating cold

Preparation process of medicinal preparation for treating bronchitis

Preparation method of drug for treating rheumatism, rheumatoid and gout

Pure traditional Chinese medicinal foot-soaking bag and preparation method thereof

Composition for preventing, ameliorating or treating dermatitis comprising complex of natural oil and natural extract treated with anion generated by plasma as effective component

The present invention relates to a composition for preventing, alleviating, or treating skin inflammation comprising a complex of natural oils and natural extracts treated with anions generated by plasma as an effective component. More specifically, the composition of the present invention comprises, as an effective component, a complex formed by mixing an oil mixture of sunflower seed oil, perilla seed oil, and apricot seed oil, with a mixed extract containing peony, morus bark, Angelica gigas, Shrubby sophora, gardenia, mugwort, Saururus chinensis (Lour.) Baill., Houttuynia cordata, Acanthopanax sieboldianum MAKINO, milkwort, and Cimicifuga heracleifolia KOM., and treating the mixture with anions generated by plasma. The composition of the present invention has excellent effects in reducing the LPS-induced formation of nitric oxide (NO) and reducing the expression of inflammatory cytokines, iNOS and IL-1β, and thus may be beneficially used as a cosmetics product, a functional health food, or a therapeutic agent for preventing or alleviating skin inflammation.

Composition for Anti-allergy Using Extracts of Ulmus davidiana and Perillae Folium

COMPOSITION FOR PREVENTING OR TREATING STERILITY COMPRISING EXTRACT OF PERILLA FRUTESCENS

The present invention relates to a composition for preventing or treating sterility, a composition for promoting pregnancy, or a composition for enhancing implantation capacity, and more specifically, to a composition for preventing or treating sterility, a composition for promoting pregnancy, or a composition for enhancing implantation capacity of an ovum within the uterus, all of which comprise an extract of Perilla frutescens as an active ingredient. The extract of Perilla frutescens according to the present invention increases expressions of leukocyte inhibitory factor (LIF) and integrins αvβ3 and αvβ5, promotes attachment of fetal trophoblast cells with endometrial cells, thereby increasing implantation efficiency within the uterus, and therefore, can be beneficially used for preventing or treating sterility. COPYRIGHT KIPO 2016 ...

PREPARATION METHOD OF REMEDIAL COMPOSITION FOR PROMOTING HAIR GROWTH AND PREVENTING HAIR GREYING

The present invention relates to a preparation method of a remedial composition for promoting hair growth and preventing hair greying, wherein the preparation method comprises: a raw material selection step for preselecting Houttuynia cordata, Perillae folium, green tea leaves, Cynanchum wilfordii, and peppermint, and removing contaminants and undesirable parts thereof; a washing step for drying the selected materials to prepare dry leaves of Houttuynia cordata, dry leaves of Perillae folium, dry green tea leaves, dry roots of Cynanchum wilfordii, and dry peppermint, and washing the dried materials with water; an extraction step for placing the washed materials in a bag and then introducing the washed materials and distilled water into a concentrating apparatus to extract a concentrated liquid; a pressing step for pressing the materials in the extraction step to separate residual concentrated liquids; a distillation step for distilling the concentrated liquids at 100°C or above, and then ...

ACNE SOLUTION

A composition for the treatment of acne includes hydrolyzed Psoralea Corylifolia, containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol(TM), which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

ТРАДИЦИОННЫЕ КИТАЙСКИЕ ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ДЕПРЕССИИ, ИХ СОСТАВ, СПОСОБ ПРИГОТОВЛЕНИЯ И ЛЕЧЕНИЯ

... 1. Традиционный китайский лекарственный препарат, отличающийся тем, что активные компоненты препарата состоят из традиционных китайских лекарственных материалов: 120-200 весовых частей плодов гардении, 300-500 весовых частей плодов форситии, 120-200 весовых частей экстракта коры магнолии или термообработанного экстракта коры магнолии с соком корневища имбиря, 180-300 весовых частей корневища пинеллии или приготовленного корневища пинеллии с соком корневища имбиря, 120-200 весовых частей плодов аурантии, 144-240 весовых частей белого домового гриба, 144-240 весовых частей периллового стебля и 36-60 весовых частей солодкового корня, ! предпочтительно, 135-185 весовых частей плодов гардении, 310-490 весовых частей плодов форситии, 130-180 весовых частей экстракта коры магнолии или термообработанного экстракта коры магнолии с соком корневища имбиря, 200-280 весовых частей корневища пинеллии или приготовленного корневища пинеллии с соком корневища имбиря, 140-190 весовых частей плодов аурантии ...

VERWENDUNG OMEGA-3-FETTSÄUREHALTIGER ÖLE ZUR ERHÖHUNG DER BIOVERFÜGBARKEIT VON PFLANZENEXTRAKTEN

Composition, useful for improving skin- and bone condition, comprises fat oils from seeds of black nettle (Perilla frutescens), vitamin C, vitamin E, calcium, vitamin K1 and vitamin D3

Composition, for improvement of skin- and bone condition, comprises fat oils from seeds of black nettle (Perilla frutescens), vitamin C, vitamin E, calcium, vitamin K1 and vitamin D3. ACTIVITY : Dermatological; Osteopathic. No biological data given. MECHANISM OF ACTION : None given.

Interferon inducers, methods for their preparation pharmaceutical compositions containing them and their use as medicaments

An interferon inducer isolated from the plant tissue, having an elemental analysis of H: 8.5-8.7 %, C: 48.8-49 %, N: 6.3-6.5 % and P: 1.0-1.1 % and a molecular weight of from about 100,000 to about 3,000,000 (mainly about 200,000 to about 1,000,000) and containing as main constituents amino acids, sugars and phosphoric acid. This substance is believed to be a homogeneous polymer of protein and sugars, containing phosphoric acid. This substance has an excellent interferon inducing activity and low toxicity and is significantly active against various viruses. The interferon inducer may be produced by extracting a substance having interferon inducing activity from the tissue of a plant of the genus Perilla of the family Labiatae or a variant thereof containing said active substance and recovering the active substance from the extract thereby obtained. Preferably, the extraction may be effected with water and the recovery may be effected by ultrafiltration. Pharmaceutical composition of this ...

ETHEREAL OIL CONTAINING PREPARATION

FORMULA AND PROCESSING TECHNOLOGY OF CYCLOCARYA PALIURUS LEAF WEIGHT-REDUCING HOT COMPRESS MEDICINE BAG

The present invention discloses a formula of a Cyclocaryapaliurus leaf weight reducing hot compress medicine bag. The Cyclocaryapaliurus leaf weight-reducing hot compress medicine package formula comprises the following components by mass: 150-200g of Cyclocarya paliurus, 20-30g of borneol, 10-15g of lotus leaves, 10 15g of poria cocos, 10-15g of rhizoma alismatis, 10-15g of coix seeds, 10-15g of perilla leaves, 10-15g of astragalus membranaceus, 10-15g of Chinese waxgourd peel, 10-15g of fresh ginger, 10-15g of white hyacinth beans, 10-15g of hawthoms, 15-20g of leonurus, 6-10g of ligusticum wallichii and 3-5g of raw rhubarb. The present invention further discloses a processing technology of a Cyclocarya paliurus leaf weight-reducing hot compress medicine bag. The processing technology comprises the following steps of (1) pre-treatment of raw materials; (2) crushing; (3) proportioning and mixing; and (4) packaging. The Cyclocarya paliurus leaf weight reducing hot compress medicine bag ...

Extracts of perilla frutescens seeds and their pharmaceutical uses

EXTRACTS OF PERILLA FRUTESCENS SEEDS AND THEIR PHARMACEUTICAL USES Abstract Disclosed is an extract of Perilla frutescens seeds that contains rosmarinic acid, luteolin, and apigenin, the weight ratio between rosmarinic acid, luteolin, and apigenin being 0.1-200 : 0.1-200 : 1. Also disclosed is a method for treating a psychiatric disorder using the above-described extract or an extract of Perilla frutescens seeds containing at least an active agent selected from the group consisting of rosmarinic acid, luteolin, and apigenin.

STABLE OPHTHALMIC OIL-IN-WATER EMULSIONS WITH SODIUM HYALURONATE FOR ALLEVIATING DRY EYE

Stable oil-in-water emulsions are described which contain a demulcent for the treatment of dry eye such as sodium hyaluronate. The oil-in-water emulsions are stable and have anti-microbial activity sufficient for use as contact lens disinfecting solutions.

COMPOSITION FOR ENHANCING HYALURONIC ACID PRODUCTIVITY AND METHOD FOR PREPARING SAME

A composition for enhancing hyaluronic acid productivity particularly in epidermic cell or tissue composed of the cell, which contains an extract of a plant belonging to the family Labiatae as an active ingredient, and a process for preparation thereof. Particularly, there is provided a cosmetic or pharmaceutical composition which can be safely and directly applied to human skin to maintain the normal skin function of a juvenile.

Traditional Chinese medicine extract and preparation for preventing asthma and preparation method thereof

Kidney-tonifying and clearing mixture and preparation method thereof

Beverage formula for alleviating hangover and preparation method of beverage formula

Preparation method of traditional Chinese medicine aromatic solid

Traditional Chinese medicine for treating renal edema and preparation method thereof

ONE-PACKAGE, COMPOSITIONS AND TREATMENT REGIMENS FOR ADMINISTRATION OF STIMULATORS OF PATHS OF PRO-RESOLVING ON KERATINOUS SURFACES

PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER CONTAINING MEDICINAL GERB EXTRACTS

COSMETIC AND PHARMACEUTICAL COMPOSITIN COMPRISING SASA QUELPAERTENSIS EXTRACT AND UREA

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR RECOVERY PHASE OF EXOGENOUS FEVER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

A traditional Chinese medicine composition for recovery phase of exogenous fever and a preparation method therefor. The traditional Chinese medicine composition comprises the following raw materials: radix codonopsis, rhizoma atractylodis macrocephalae, poria cocos, radix ophiopogonis, schisandra chinensis, hairyvein agrimony, perilla seeds, cortex moriradicis, folium eriobotryae, radix platycodi, apricot kernels, and radix glycyrrhizae. According to the monarch, minister, assistant and guide theory of traditional Chinese medicines, the radix codonopsis is used as a monarch drug; fried rhizoma atractylodis macrocephalae, the poria cocos, the radix ophiopogonis, the schisandra chinensis, and the hairyvein agrimony are used as minister drugs; the perilla seeds, the cortex moriradicis, and the folium eriobotryae are used as assistant drugs; and the radix platycodi, the apricot kernels, and the radix glycyrrhizae are used as guide drugs. Also disclosed is use of the traditional Chinese medicine ...

ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING OMEGA-3 FATTY ACIDS AND PLANT EXTRACTS CONTAINING ISOPRENOIDS AND THE USE THEREOF

The invention relates to active ingredient combinations of plant oils containing 3-fatty acids and plant extracts containing isoprenoids with improved tolerance and the use thereof for reducing an elevated blood cholesterol level, for the prevention or treatment of an artherosclerosis or coronary heart disease and for the prevention or treatment of a disease related to a sex hormone.

ТРАДИЦИОННЫЕ КИТАЙСКИЕ ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ДЕПРЕССИИ, ИХ СОСТАВ, СПОСОБ ПРИГОТОВЛЕНИЯ И ЛЕЧЕНИЯ

FIELD: medicine, pharmaceutics. SUBSTANCE: invention relates to pharmaceutical industry, in particular to medications for treatment of depression. Traditional Chinese medication for treatment of depression. Method of preparing traditional Chinese medication for treatment of depression. Product. Pharmaceutical composition for treatment of depression. Method of preparing pharmaceutical composition (versions). Application of traditional Chinese medication in production of medications for treatment of depression. Application of product for production of medication for treatment of depression. Method of depression treatment (versions). EFFECT: medications are efficient for treatment of depression. 21 cl, 14 tbl, 7 ex РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 2 426 553 (13) C2 (51) МПК A61K A61K A61K A61K A61K A61K ФЕДЕРАЛЬНАЯ СЛУЖБА A61K ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, A61K ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ A61K A61P (12) ОПИСАНИЕ 36/9068 (2006.01) 36/076 (2006.01) 36/484 (2006.01) 36/535 (2006.01) 36/575 (2006.01) 36/634 (2006.01) 36/72 (2006.01) 36/744 (2006.01) 36/8888 (2006.01) 25/24 (2006.01) ИЗОБРЕТЕНИЯ К ПАТЕНТУ (21)(22) Заявка: 2008132895/15, 11.01.2007 (24) Дата начала отсчета срока действия патента: 11.01.2007 (72) Автор(ы): ВУ Йилинг (CN), ХУАНГ Хуанг (CN) R U (73) Патентообладатель(и): Хэбэй Йилинг Медисин Ресерч Инститьют Ко. Лтд. (CN) Приоритет(ы): (30) Конвенционный приоритет: 11.01.2006 CN 200610000657.3 (43) Дата публикации заявки: 20.02.2010 Бюл. № 5 2 4 2 6 5 5 3 (45) Опубликовано: 20.08.2011 Бюл. № 23 (56) Список документов, цитированных в отчете о поиске: CN 1579461 А, 16.02.2005. CN 1232694 А, 27.10.1999. CN 1390585 А, 15.01.2003. CN 1390588 А, 15.01.2003. 2 4 2 6 5 5 3 R U (86) Заявка PCT: CN 2007/000109 (11.01.2007) C 2 C 2 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 11.08.2008 (87) Публикация заявки РСТ: WO 2007/079691 (19.07.2007) Адрес для переписки: 119034, Москва, Пречистенский пер., 14, стр. 1, 4-ый этаж, "Гоулингз Интернэшнл, Инк.", ...

Композиция, содержащая виценин-2, обладающая благоприятным воздействием на неврологическую или когнитивную функцию

... 1. Применение виценина-2 или его биологически активного аналога в качестве активного ингредиента для поддержания и/или улучшения неврологической функции и/или функции головного мозга и/или предупреждения, задержки начала, регулирования и/или лечения неврологической дисфункции, состояния, расстройства или заболевания.2. Применение по п. 1 в качестве активного ингредиента для поддержания и/или улучшения неврологической функции и/или функции головного мозга.3. Применение по п. 1, где неврологическая дисфункция, состояние, расстройство или заболевание представляет собой связанную с возрастом или стрессом неврологическую дисфункцию, тревогу, когнитивное расстройство, депрессию или деменцию, где деменция представляет собой предпочтительно болезнь Альцгеймера.4. Применение по п. 1, где активный ингредиент получен из растения.5. Применение по п. 4, где активный ингредиент входит в состав препарата растительного происхождения, обогащенного активным ингредиентом.6. Применение по п. 4, где растение ...

PHARMACEUTICAL ASTHMA PREPARATION

USE OF THE FRUITS OF A PLANT OF THE KIND OCIMUM FOR THE PRODUCTION OF A PREPARATION APPROXIMATELY FETTLEIBIGHEIT.

USE OMEGA-3-FETTSÄUREHALTIGER OF OILS FOR THE INCREASE OF THE BIO-AVAILABILITY OF PLANT EXTRACTS

Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use

A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.

A composition having a prebiotic effect

Provided are food, dietary supplements and/or drug compositions having prebiotic effect and their use in human and animal care.

Methods and compositions for treating skin to resolve inflammation and screening for actives that stimulate pro-resolution pathways

Compositions and methods for treating inflamed skin with Pro-Resolution Pathway Stimulators that may be Inflammatory Metabolite Inhibitors, Pro-Resolving Activators, or combinations thereof, and a method for screening active ingredients for activity as Pro-Resolution Pathway Stimulators for incorporation into topical cosmetic products.

LTBP-1 expression promoting composition and method for screening for substance having LTBP-1 expression promoting function

The purpose of the present invention is to provide a LTBP-1 expression promoting composition that promotes LTBP-1 expression and a method for screening for a substance having a LTBP-1 expression promoting function, etc. The present invention relates to a LTBP-1 expression promoting composition, including an extract of one or more plants selected from the group consisting of rose, jiaogulan, Roberts geranium, calamus, beefsteak plant, sage, and star fruit. The rose contains a rosacyanine compound and/or a rosadelphin compound.

PHARMACEUTICAL COMPOSITION COMPRISING EDIBLE ACIDS OR THE ACID SALTS AND ITS USE

The invention relates to pharmaceutical compositions for treatment or amelioration of immunity disease through reducing PH of body fluid. Uses of edible acid and/or acid salt, or fruits comprising edible and/or acid salt or their products, in preparation of food, drink or health care products, for improving individual immunity; preparation of food for reducing risk of hypersensitive response. Medical preparation in the use of prevention or treatment of cold, insect biting, dermatitis, or in the use of glove-treating agent, transdermal agent.

METHODS AND COMPOSITIONS FOR TREATING SKIN TO RESOLVE INFLAMMATION AND SCREENING FOR ACTIVES THAT STIMULATE PRO-RESOLUTION PATHWAYS

Compositions and methods for treating inflamed skin with Pro-Resolution Pathway Stimulators that may be Inflammatory Metabolite Inhibitors, Pro-Resolving Activators, or combinations thereof, and a method for screening active ingredients for activity as Pro-Resolution Pathway Stimulators for incorporation into topical cosmetic products.

UNIT DOSE PACKAGES, COMPOSITIONS, AND TREATMENT REGIMENS TO DELIVER PRO-RESOLUTION PATHWAY STIMULATORS TO KERATIN SURFACES

Ampoule containing a Pro-Resolution Pathway Stimulator, methods for making, and treating for skin having discrete areas of inflammation using ampoule composition containing Pro-Resolution Pathway Stimulator.

ACNE SOLUTION

A composition for the treatment of acne includes hydrolyzed psoralea corylifolia, containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In various implementations, the composition is a water-based acne gel or a water-based cleanser. In a specific implementation, a composition includes Bakutrol(TM), which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid, benzoyl peroxide, tretinoin, retinol, tazarotene, or an antibiotic, or a combination of these. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

VICENIN 2 AND ANALOGUES THEREOF FOR USE AS AN ANTISPASMODIC AND/OR PROKINETIC AGENT

Provided are compositions comprising an active ingredient having antispasmodic and/or prokinetic activity, preferably vicenin 2 or biologically active analogues thereof.

Compound Chinese herbal medicine agent as well as preparation method and application thereof

Traditional Chinese medicine for treating peptic ulcer and preparation method thereof

Traditional Chinese medicine composition for treating tinea manus and pedis

Application of traditional Chinese medicine composition in treating diseases caused by mucosal injury

Granules for treating qi and blood deficiency type pregnancy vertigo

Traditional Chinese medicine mosquito repellent liquid

Traditional Chinese medicine foot-bath composition with effect of conditioning postpartum syndromes as well as preparation method and application thereof

Flatulence eliminating and eructation reducing decoction

Traditional Chinese medicine preparation for treating non-infectious fever after orthopedic operation and preparation method thereof

Traditional Chinese medicine coating for treating urticaria type urticaria and preparation method thereof

A method for reducing stress of the piglet transportation additive and use thereof

Chinese medicinal formula for treating gastric ulcer

Preparation method for Huoxiang Zhengqi admixture

Traditional Chinese medicinal composition for treating pancreatitis

Dingchuan decoction traditional Chinese medicine preparation

Drug composition for treating asthmatic bronchitis

Process of stabilization of derived from amides of higher fatty-acids

PHARMACEUTICAL COMPOSITION COMPRISING LUTEOLIN-7-O-DIGLUCURONIDE, APIGENIN-7-O-DIGLUCURONID ISOLATED FROM PERILLA FRUTESCENS VAR. ACUTA LEAF EXTRACT FOR IMPROVING OCULAR FATIGUE

A DRUG FOR TREATING COLD AND ITS PREPARATION METHOD

COMPOSITION FOR IMPROVING IMMUNE ACTIVITY CONTAINING LACTOBACILLUS

COMPOSITION FOR PREVENTING HAIR LOSS AND STIMULATING HAIR GROWTH COMPRISING COMBINED EXTRACT CONSISTING OF HEAT-PROCESSED GINSENG, HOUTTUYNIAE HERBA, PERILLA LEAF AND GREEN TEA LEAVES AS ACTIVE INGREDIENT

The present invention relates to a composition containing an extract of combined medicinal herbs consisting of heat-treated ginseng, Houttuyniae herba, perilla leaf and green tea leaves, or a processed extract thereof as active ingredients for preventing hair loss and stimulating hair growth. Through various animal model experiments such as an experiment to measure a hair-growing effect using 6-week old male C57BL/6 mice (Experimental Example 1); and an experiment to measure an activating effect on the differentiation and proliferation of hair follicle dermal papilla cells (HFDPC) (Experimental Example 2), it was confirmed that the processed combined extract of the present invention showed far more potent hair-growth promoting effects than the fermented extract of Houttuyniae herba, perilla leaf and green tea leaf disclosed in the prior art document (Korean Patent Publication No. 10-2014-0114492). Therefore, the composition of the present invention can be beneficially used for treating ...

desinfetante mucoso não tóxico contendo álcool isopropìlico, óleo de gergelim, aloés e óleo de limão

Composition for treatment of asthma

The present invention discloses a pharmaceutical preparation of Chinese herbal medicines which consists of Chinese herbal medicines for tonifying kidney and antiasthma, wherein the Chinese herbal medicines are Perilla Frutescens, Prunus Armeniaca, Glycyrrhiza Uralensis, Scutellaria Baicalensis, Coptis Chinesis, Tusilago Farfara, Stemona Sessilifolia, Fritllaria Cirrhosa, Pheretima Aspergillum, Psoralea Corylifolia, Codonopsis Pilosula, Hordeum Vulgara, Massa Fermentata Medicalis, Schisandra Chinensis, Gypsum. The preparation has been used in China for 20 years, and in Israel for more than 5 years. It has been used to treat thousands of patients suffering from asthma with an effective rate of 93%. The present preparation can relieve cough, expel phlegm, resist airway allergic inflammation reaction, improve pulmonary function, partial pressure of the oxygen in blood and increase CD2, CD4, CD4/CD8, reduce IgE in blood, and increase CAMP, reduce CGMP, stabilize mast cells, inhibit the release ...

Nasal composition

The present invention relates to a nasal composition comprising an anti-allergic oil derived from plant; and an oil-based barrier-forming preparation. The composition may be used in preventing and/or treating allergic disorders of the nasal cavity, including seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis.

COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS USING ALGAE BASED OILS AND ASTAXANTHIN

In accordance with a non-limiting example, an algae based oil is used in place of a krill oil to treat low density lipoprotein (LDL) oxidation in humans by administering a therapeutic amount of a dietary supplement composition comprising an algae based oil comprising glycolipids and phospholipids and Eicosapentaenoic (EPA) fatty acids in combination with astaxanthin derived from Haematococcus pluvialis (Hp) in an oral dosage form, wherein the astaxanthin derived from Haematococcus pluvialis (Hp) is 0.1 to 2.7 percent by weight of the algae based oil.

Agent for prevention of deterioration of milk-containing foods

Disclosed are a deterioration preventive agent for milk-containing foods containing as its active ingredient a coumarin analog represented by the general formula (1) below, a glycoside of that analog, or a plant extract containing the coumarin analog or its glycoside: (wherein R1 represents a hydrogen atom, a hydroxyl group or a methoxy group, R2 represents a hydrogen atom or a hydroxyl group, and R1 and R2 are not both hydrogen atoms). The deterioration preventive agent according to the present invention demonstrates superior deterioration preventive effects for milk-containing foods. In addition, the deterioration preventive agent provided by the present invention is friendly to the environment and people.

ТРАДИЦИОННАЯ КИТАЙСКАЯ ЛЕКАРСТВЕННАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ БРОНХИАЛЬНОЙ АСТМЫ И СПОСОБ ЕЕ ПРИГОТОВЛЕНИЯ

Настоящее изобретение относится к композиции традиционного китайского лекарственного средства для лечения бронхиальной астмы и способу ее приготовления. Традиционная китайская лекарственная композиция готовится из чистых растительных сырьевых лекарственных средств, включающих траву эфедры (Herba Ephedrae), семена гингко (Semen Ginkgo), кору шелковицы (Cortex Mori), корень шлемника (Radix Scutellariae), семена абрикоса горького (Semen Armeniacae Amarum), корневище пинеллии (Rhizoma Pinelliae), плоды периллы (Fructus Perillae), цветки мать-и-мачехи (Flos Farfarae), корень пиона красного (Radix Paeoniae Rubra), траву гуттуинии (Herba Houttuyniae), корень трихозана (Radix Trichosanthis), плоды форзиции (Fructus Forsythiae). Традиционная китайская лекарственная композиция эффективна при лечении бронхиальной астмы. 2 н. и 9 з.п. ф-лы, 7 табл., 12 пр.

НЕТОКСИЧЕСКИЕ ДИЗИНФЕКТАНТЫ СЛИЗИСТЫХ ОБОЛОЧЕК, СОДЕРЖАЩИЕ ИЗОПРОПИЛОВЫЙ СПИРТ, КУНЖУТНОЕ МАСЛО, АЛОЭ И ЛИМОННОЕ МАСЛО

... 1. Нетоксическая композиция дезинфектанта слизистой оболочки однородно смешанных компонентов для местного нанесения в нос, включающая изопропиловый спирт по меньшей мере 50 мас.%, кунжутное масло не более 45 мас.%, лимонное масло или лимонную мяту не более 3 мас.% для дополнения и нейтрализации обезвоживающего эффекта указанного спирта и алоэ или производное алоэ, не более 10 мас.%. 2. Композиция дезинфектанта по п.1, в которой указанное алоэ представляет собой алоин с эмодином. 3. Композиция по п.1, в которой указанное кунжутное масло составляет приблизительно 41 мас.%, указанное лимонное масло или лимонная мята составляет приблизительно 2 мас.% и указанное алоэ или производное алоэ составляет приблизительно 5 мас.%. 4. Композиция дезинфектанта по п.1, которая дополнительно включает приблизительно от 0,5 до 2 мас.% экстракта семян грейпфрута и приблизительно от 0,5 до 2 мас.% глюконата хлоргексидина. 5. Композиция дезинфектанта по п.1, в которой указанный изопропиловый спирт является по ...

КОМБИНАЦИЯ АНТИАЛЛЕРГИЧЕСКОГО АГЕНТА С АНТАГОНИСТОМ МУСКАРИНОВЫХ РЕЦЕПТОРОВ И/ИЛИ АГОНИСТОМ ДОФАМИНЕРГИЧЕСКИХ РЕЦЕПТОРОВ ДЛЯ ПРИМЕНЕНИЯ С ЦЕЛЬЮ ПРОФИЛАКТИКИ/ОСТАНОВКИ ПРОГРЕССИРОВАНИЯ АКСИАЛЬНОЙ МИОПИИ У ЧЕЛОВЕКА

Zusammensetzungen enthaltend omega-3-fettsäurehaltige Öle und Pflanzenextrakte

Die vorliegende Erfindung betrifft Zusammensetzungen, die omega-3-fettsäurehaltige Öle und Pflanzenextrakte enthalten, und deren Verwendung als diätetisches Nahrungsmittel oder Arzneimittel bzw. pharmazeutische Zubereitung mit erhöhter Bioverfügbarkeit der in den Zubereitungen enthaltenen sekundären Pflanzeninhaltsstoffe.

ÄTHERISCHES ÖL BEINHALTENDE ZUBEREITUNG

Unit dose packages, compositions, and treatment regimens to deliver pro-resolution pathway stimulators to keratin surfaces

A unit dose package containing a composition comprising at least one Pro-Resolution Pathway Stimulator is provided. The unit dose package may be a capsule, preferably an ampoule, or a facial treatment mask. The Pro-Resolution Pathway Stimulator may comprise an Inflammatory Metabolite Inhibitor, a Pro-Resolving Activator, a mixture of an Inflammatory Metabolite Inhibitor and a Pro-Resolving Activator, or both an Inflammatory Metabolite Inhibitor and a Pro-Resolving Activator. Preferably the Pro-Resolving stimulator comprises a Pro-Resolving Activator that stimulates an increase in cellular concentration of Pro-Resolution lipid mediators, in particular Resolvin, Protectin, Lipoxin and Maresin. Preferably the pro-resolution pathway stimulators are selected from omega-3/omega-6 fatty acids, salicylic acid, resveratrol, resveratrol salicylate, Perilla ocymoides seed oil, Camellia japonica extract, Poria cocos extract, Aleurites moluccana (Kukui) seed oil, Camelina sativa seed oil, Dongbaek ( ...

Chinese Herbal Medicine Bait for Improving Disease Resistance Immunity of Grass Carp

Chinese herbal medicine bait for improving disease resistance immunity of grass carp comprises: Coptis chinensis, rhubarb, Scutellaria baicalensis Georgi, Isatis tinctoria, Forsythia suspensa, Perillafrutescens, Acorus tatarinowii, nutgall, ginger, garlic, and powder mixture. Grass carp feed formula is: wheat middlings, imported fish meal, beer yeast powder, wheat bran, rice bran meal, 46% soybean meal, rapeseed meal, stone powder, soybean oil, salt, calcium hydrogen phosphate, MZ, phytase, complex enzyme, choline, 98.5% lysine, 99% threonine, VC, VE, antioxidant and mildew inhibitor. Add the Chinese herbal medicines into the feed in proportion of 1%-1.5%. Then make the feed into medicine bait particles with different particle sizes. The bait does not pollute the environment and is not enriched in fish. It facilitates the prevention and treatment of large-scale fish diseases, reduces the mortality and increases growth rate.

Herbs and herbal combinations useful for the treatment of microbial infections

COMPOSITIONS FOR PREVENTING OR TREATING POLLENOSIS, ALLERGIC NEPHRITIS, ATOPIC DERMATITITS, ASTHMA OR URTICARIA

Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use

A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.

ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING .OMEGA.3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF

The invention relates to active ingredient combinations of oils containing .omega.3-fatty acids and plant extracts containing polyphenols and the use thereof for the treatment of inflammatory and/or immunological and metabolic diseases and other ailments.

COMPOSITIONS FOR PREVENTING OR TREATING POLLENOSIS, ALLERGIC NEPHRITIS, ATOPIC DERMATITITS, ASTHMA OR URTICARIA

Compositions for treating pollinosis, allergic nephritis, atopic dermatitis, asthma or urticaria, health foods or functional foods which contain two crude drugs of pumpkin seeds and safflower together with at least one crude drug selected from among Plantago asiatica L., Louicera japonica Thunberg, Glycyrrhizae Radix, Coix lacryma-jobi Linne var. ma-yuen, Zingiberis Rhizoma, Turmeric, Zedoary and Artemisiae Argyi Forium as the active ingredients.

OIL-AND-FAT COMPOSITION, AND FOOD OR BEVERAGE CONTAINING THEOIL-AND-FAT COMPOSITION

Disclosed is an oil-and-fat composition having a high .alpha.-linolenic a cid content, a hypertension-ameliorating effect, a good flavor, and good sto rage stability. Also disclosed is a food or beverage containing the oil-and- fat composition. The oil-and-fat composition comprises at least one plant oi l A selected from flax oil, perilla oil and perilla seed oil, rice oil, and at least one plant oil B selected from rape seed oil, soybean oil and corn o il at a ratio among the plant oil A, rice oil and the plant oil B [i.e., a ( plant oil A)/(rice oil)/(plant oil B) ratio] of 20-35/15-25/40-65 by mass, w herein the .alpha.-linolenic acid content in the constituent fatty acids con tained in the oil-and-fat composition is 15 to 30 mass%.

COMBINATION OF AN ANTIALLERGIC AGENT WITH MUSCARINIC ANTAGONIST AND/OR DOPAMINERGIC AGONIST FOR USE IN PREVENTING/STOPPING OF AXIAL MYOPIA IN HUMAN

One of the major issues against the use of muscarinic antagonists or dopamine agonist eyedrops for the controlling of eye growth and prevention of myopia is the unacceptable rate of iatrogenic conjunctivitis or dermatitis. This invention relates to the association of those active principles with an antiallergic component. In alternative the ophthalmic use of a molecule that simultaneously has an antimuscarinic and/or dopaminergic action along with an antihistaminic function.

Ligusticum chuanxiong Hort-Folium Perillae exterior syndrome relieving decoction

Yellow rice wine for preventing and treating stomach deficiency type pernicious vomiting

Fetus protection and miscarriage prevention traditional Chinese herbal compound and preparation method thereof

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

Sinonasal Specimen Collection Kit and Use

The present invention additionally provides a kit for collecting the sinonasal specimen to analyze which pathogenic microbes cause a disease in a mammal, how to test the drug sensitivity against the infectious microbes in sinonasal cavities, and to help the selection of a pharmaceutical composition to selectively treat a disease of a mammal. The present invention also provides a pharmaceutical composition comprising a chemical compound or a herb extract or the combination having at least one of the activities of antiviral, antibacterial, antifungal, anti-inflammatory, anti-allergy, anti-cancer, promoting membrane healing or immunomodulating, for the treatment and prevention of a disease of a mammal. The invented method of treating a human disease reduces infectious and inflammation without causing antibiotic resistance or clinically noticeable adverse event.

OXIDIZED PROTEIN HYDROLASE ACTIVITY ENHANCING AGENT

The present invention provides a novel oxidized protein hydrolase activity enhancing agent. The oxidized protein hydrolase activity enhancing agent of the present invention contains at least one kind of plant extract obtained from a plant selected from the group consisting of water chestnut, stevia, rosemary, thyme, chrysanthemum, savory, mugwort, chestnut, spearmint, marjoram, peppermint, lemon balm, allspice, perilla, basil, and caraway. 1. (canceled)2. (canceled)3. A method for enhancing activity of oxidized protein hydrolase in a sample , comprising:adding oxidized protein hydrolase activity enhancing agent to the sample.4. A method for accelerating protein degradation in a sample comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'adding an oxidized protein hydrolase activity enhancing agent according to to the sample.'}5. (canceled)6. A method for treating senescence of tissues caused by accumulation of AGEs in a subject , the method comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'administering an oxidized protein hydrolase activity enhancing agent according to .'}7. A method for treating hypofunction of tissues caused by accumulation of AGEs in a subject , the method comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'administering an oxidized protein hydrolase activity enhancing agent according to .'}8. The method according to claim 3 , wherein the oxidized protein hydrolase activity enhancing agent comprises two or more kinds of plant extracts selected from the group consisting of those obtained from water chestnut claim 3 , stevia claim 3 , rosemary claim 3 , thyme claim 3 , chrysanthemum claim 3 , savory claim 3 , mugwort claim 3 , chestnut claim 3 , spearmint claim 3 , marjoram claim 3 , peppermint claim 3 , lemon balm claim 3 , allspice claim 3 , perilla claim 3 , basil claim 3 , and caraway.9. The method according to claim 4 , wherein the oxidized protein hydrolase activity enhancing agent comprises two or more kinds ...

COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING PHOSPHOLIPIDS AND ASTAXANTHIN

A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. 1. A method to treat and alleviate symptoms of joint pain by administering to a person having joint pain a therapeutic amount of a dietary supplement composition , including astaxanthin , pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) , and a marine or seed oil and including a lipid selected from the group consisting of a phospholipid , glycolipid , and sphingolipid , and formulated into an oral dosage form , wherein the astaxanthin is 0.1 to 15 percent by weight of the marine or seed oil and the lipid selected from the group consisting of the phospholipid , glycolipid and sphingolipid.2. The method according to claim 1 , wherein the astaxanthin comprises a natural or synthetic ester or synthetic diol derivative.3. The method according to claim 1 , further comprising adding a pharmaceutical or food grade diluent to the marine or seed oil and the lipid selected from the group consisting of the phospholipid claim 1 , glycolipid and sphingolipid.4. The method according to claim 1 , wherein the phospholipid is selected from the group consisting of Phosphatidylcholine claim 1 , Phosphatidylethanolamine claim 1 , Phosphatidylserine claim 1 , Phosphatidylinositol claim 1 , Phosphatidic acid claim 1 , Lyso-Phosphatidylcholine claim 1 , Lyso-Phosphatidylethanolamine claim 1 , and Lyso-Phosphatidylserine.5. The ...

METHOD FOR PRODUCING RED PERILLA LEAF EXTRACT

Provided is a method for producing a red leaf extract which enables to collect rosmarinic acid with a high yield from red leaves to which an acid is added. The method for producing a red leaf extract includes the following step (1): (1) a step of extracting red leaves to which an acid has been added with water under a condition of a pH of from 4.0 to 8.0. 1perilla. A method for producing a red leaf extract , the method comprising:{'i': 'perilla', '(1) extracting red leaves to which an acid has been added with water under a condition of a pH of from 4.0 to 8.0.'}2perilla. A method for producing a purified red leaf extract , the method comprising:{'i': 'perilla', '(1) extracting red leaves to which an acid has been added with water under a condition of a pH of from 4.0 to 8.0 to form an extract solution;'}(2) concentrating the extract solution obtained in the extracting (1) to form a concentrated extract solution; and(3) adding ethanol or an ethanol aqueous solution to the concentrated extract solution obtained in the concentrating (2) and then removing a precipitate.3. The producing method according to claim 1 , wherein an extraction temperature in the extracting (1) is 50° C. or more.4. The producing method according to claim 2 , wherein claim 2 , in the step-extracting (1) claim 2 , a bath ratio of water is from 4 to 35 (L/kg).5. The producing method according to claim 2 , wherein claim 2 , in the step adding (3) claim 2 , ethanol or an ethanol aqueous solution is added to the concentrated extract solution such that an ethanol concentration is from 40 to 95 vol %.6. The producing method according to claim 2 , wherein claim 2 , in the concentrating (2) claim 2 , the pH of the extract solution obtained in the extracting (1) is further optionally adjusted to a pH of from 4.0 to 7.5 before the concentrating or the pH of the concentrated extract solution is further optionally adjusted to a pH of from 4.0 to 7.5 after the concentrating.7. The producing method according ...

Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans

A composition and method which improves blood lipid profiles and optionally reduces low density lipoprotein (LDL) per-oxidation in humans by administering a therapeutic amount of a composition comprising krill oil in combination with astaxanthin or a mixture of fish oil derived, choline based, phospholipid bound omega-3 fatty acid mixture including phospholipid bound polyunsaturated EPA and DHA. In one embodiment, the krill oil is derived from Euphasia spp., comprising Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids in the form of triacylglycerides and phospholipids. The krill oil includes at least 10% EPA and 5% DHA, of which greater than 50% are in the form of phospholipids and the 1-4000 mg of krill oil per daily dose is delivered.

METHOD AGAINST CORONAVIRUS INFECTION WITH WATER-EXTRACTED PRODUCT OF PERILLA FRUTESCENS

Disclosed herein is a method against coronavirus infection, which includes administering to a subject in need thereof a composition containing a water-extracted product of 1Perilla frutescens.. A method against coronavirus infection , comprising administering to a subject in need thereof a composition containing a water-extracted product of2. The method according to claim 1 , wherein the coronavirus infection is caused by a coronavirus selected from the group consisting of severe acute respiratory syndrome coronavirus (SARS-CoV) claim 1 , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) claim 1 , middle east respiratory syndrome coronavirus (MERS-CoV) claim 1 , human coronavirus 229E (HcoV-229E) claim 1 , and combinations thereof.3. The method according to claim 1 , wherein the composition is a pharmaceutical composition.4. The method according to claim 3 , wherein the pharmaceutical composition is in a dosage form for oral administration.5. The method according to claim 3 , wherein the pharmaceutical composition is in a dosage form for parenteral administration. This application claims priority to Taiwanese Invention Patent Application No. 109132586, filed on Sep. 21, 2020.The present disclosure relates to a method against coronavirus infection with a composition containing a water-extracted product of(L.) Britt., commonly known as or wild sesame seed, is a species of in the mint family Lamiaceae. is an important economic crop and with a long cultivation history in China as well as some other countries in Asia. Except for the edible applications, the plant of has been also traditionally used as a medicinal herb in China for thousands years. The leaves, seeds, and stems of are recommended by the Chinese Pharmacopeia as three medicinal materials for various therapeutic applications. has been used as an important traditional herbal medicine for treating various diseases/disorders including depression, anxiety, tumors, asthma, cough, allergy, intoxication, ...

NANOPARTICLE OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR DISORDERS OR DISEASES

Is herein described a nanoparticle ophthalmic composition comprising at least 0.1% of extract and at least 0.1% of hyaluronic acid or a salt thereof wherein the extract has a content of polyphenols of at least 2.5% by weight of the total weight of the extract and to the use of said ophthalmic composition in the treatment of ocular disorders or diseases such as tear dysfunction syndrome, dry eye, diabetic retinopathy and glaucoma, preferably in the treatment of tear dysfunction syndrome. 2) A nanoparticle ophthalmic composition according to wherein the ophthalmic composition is a sterile liquid formulation.3) A nanoparticle ophthalmic composition of claim 2 , wherein the sterile liquid formulation is selected from the group consisting of eye drops claim 2 , semi-solid formulations claim 2 , creams and gels.4) A nanoparticle ophthalmic composition according to wherein the sterile liquid formulation is in the form of eye drops.5Perilla frutescens) A nanoparticle ophthalmic composition according to containing from about 0.1% to about 5% by weight of a extract with respect to the total weight of the ophthalmic composition.6Perilla frutescens) A nanoparticle ophthalmic composition according to containing from about 0.1% to about 0.2% by weight by weight of a extract with respect to the total weight of the ophthalmic composition.7Perilla frutescens) A nanoparticle ophthalmic composition according to containing from about 0.10% to about 0.15% by weight of a extract with respect to the total weight of the ophthalmic composition.8) A nanoparticle ophthalmic composition according to containing from about 0.1% to about 0.5% by weight of hyaluronic acid or a salt thereof with respect of the total weight of the ophthalmic composition.9) A nanoparticle ophthalmic composition according to containing about 0.25% by weight of hyaluronic acid or a salt thereof with respect of the total weight of the ophthalmic composition.10) A nanoparticle ophthalmic composition according to wherein ...

PERILLA SEED COMPOSITION

A composition of matter comprises a shelf stable, partially defatted supercritical COfluid solvent extracted whole grain flour derived from a cracked biomass of the flour comprising minerals and 2 to 8 percent of native seed oil, 35 to 45 percent protein, and 35 to 45 percent fiber. 1perilla frutescens,. A method of treating cardiovascular disease in humans or animals by administering an effective amount of a dietary supplement , food or beverage that has added thereto a composition comprising a shelf stable , partially defatted supercritical CO2 fluid solvent extracted whole grain flour derived from a cracked biomass of the flour comprising minerals and 2 to 8 percent of native seed oil , 35 to 45 percent protein , and 35 to 45 percent fiber.2. The method according to claim 1 , and further comprising forming a beverage claim 1 , liquid concentrate claim 1 , or dried beverage pre-mixes to which the composition is added.3. The method according to claim 1 , and further comprising preparing liquid concentrates or dried pre-mixes including protein shakes claim 1 , fruit smoothies claim 1 , ready-to-drink beverages claim 1 , dry beverage pre-mixes claim 1 , frozen fruit concentrates claim 1 , aqueous alcoholic beverage pre-mixes claim 1 , concentrates or their dried pre-mixes claim 1 , vitamin claim 1 , carbohydrate and protein fortified meal replacement beverages claim 1 , drinkable dairy and non-dairy yogurts claim 1 , gravies and dry gravy pre-mixes claim 1 , and ready-to-drink and dried pre-mixed infant formulas.4. The method according to claim 1 , and further comprising thickening a resulting final beverage by adding one or more acidulants for adjusting the pH from between about 3 to about 6.5.5. The method according to claim 1 , wherein the flour contains about 2 to about 3 percent fructo-oligosaccharides.6. The method according to claim 1 , wherein the flour exhibits pH dependent thixotropic properties when mixed with water.7. The method according to claim 1 , ...

Agent for Preventing or Amelioriting Noctura

An agent for preventing or ameliorating nocturia, containing rosmarinic acid or a salt thereof as an active ingredient. 113.-. (canceled)14. A method of preventing or ameliorating nocturia , comprising administering or ingesting rosmarinic acid or a salt thereof to or by a subject.1516.-. (canceled)17. The method according to claim 14 , wherein the rosmarinic acid or the salt thereof is in an extract of a plant belonging to the Lamiaceae family containing rosmarinic acid or a salt thereof.18Perilla frutescensacuta. The method according to claim 17 , wherein the plant is Britton var. Kudo.19. The method according to claim 17 , wherein the ratio of rosmarinic acid or a salt thereof in the extract of the plant with respect to the extract solid content in terms of rosmarinic acid content is 0.1 mass % or more and 100 mass % or less.20. The method according to claim 14 , wherein the compound is administered to or ingested by a subject who wants or needs prevention claim 14 , amelioration claim 14 , or treatment of nocturia.21. The method according to claim 20 , wherein the age of the subject is 20 years old or older.22. The method according to claim 14 , wherein the amount of administration or intake of the rosmarinic acid or the salt thereof in terms of rosmarinic acid content for one (1) adult (body weight 60 kg) per one (1) day is 0.1 mg or more and 40 claim 14 ,000 mg or less.23. The method according to claim 14 , wherein the blending amount or the content of the rosmarinic acid or the salt thereof in terms of rosmarinic acid content is 0.01 mass % or more and 100 mass % or less.24. The method according to claim 14 , wherein the blending amount or the content of the rosmarinic acid or the salt thereof in terms of rosmarinic acid content is 0.001 mass % or more and 50 mass % or less.25. The method according to claim 14 , wherein the rosmarinic acid or the salt thereof is ingested or administered once a day or divisionally several times a day or during an arbitrary ...

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products. 1Rhodiola roseaPerilla frutescensPhellodendron amurenseFoeniculum vulgareSantalum albumHordeum distichonCitrus reticulata{'i': Rhodiola rosea', 'Perilla frutescens', 'Phellodendron amurense', 'Foeniculum vulgare', 'Santalum album', 'Hordeum distichon', 'Citrus reticulata, '(i) blending rhizome, fruit, bark, and seed, stem, seed, and peel to provide a blend of extracts;'}(ii) fermenting the blend of extracts with a microorganism, wherein the microorganism can be yeast cells, and culturing nutrients; or(iii) fermenting the blend of extracts with microorganisms, wherein said microorganisms can be yeast cells, in an aqueous environment in substantial absence of additional nutrients or low nutrient media to catabolically process the blend of extracts;(iv) monitoring the fermentation of (ii) or (iii) for signs of plateauing biological activity;(v) briefly raising the temperature to rupture the yeast cells to release yeast cell contents, or disrupting the yeast cells by sonication; and(vi) filtering to remove yeast cell debris and to recover the blend of fermented extracts, wherein the blend of fermented extract has reduced odor and/or color, wherein the blend of fermented extracts is in the form of a fine powder, and wherein the topical composition further comprises a cosmetically or pharmaceutically acceptable carrier.. A topical composition for restoring Yin-Yang balance of skin of a person with Yin-dominant or balanced-to-Yin skin, said composition comprising ...

THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID ROE EXTRACT COMPOSITION AND ASSOCIATED METHOD

A dietary supplement composition to treat low density lipoprotein (LDL) oxidation in humans includes a therapeutic amount of a phospholipid rich egg roe extract having at least 50 percent phospholipids and a seed oil extract in combination with astaxanthin in an oral dosage form. The astaxanthin is 0.1 to 15 percent by weight of the at least phospholipid rich egg roe extract. 1. A dietary supplement composition to treat low density lipoprotein (LDL) oxidation in humans , wherein the dietary supplement composition comprises a therapeutic amount of a phospholipid rich egg roe extract and a seed oil extract in combination with astaxanthin in an oral dosage form , wherein the astaxanthin is 0.1 to 15 percent by weight of the phospholipid rich egg roe extract.2. The composition according to claim 1 , wherein the phospholipid rich egg roe extract comprises Eiconsapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids wherein the amount of DHA is at least 50 percent greater than the amount of EPA.3. The composition according to claim 1 , comprising 150 to 500 mg of phospholipid rich egg roe extract and 0.5 to 12 mg of astaxanthin claim 1 , and wherein the composition is encapsulated into a single dosage capsule.4. The composition according to claim 1 , wherein the seed oil extract comprises an extract having an alpha-linolenic acid (ALA) to linoleic acid (LA) ratio between 1:1 and 6:1.5. The composition according to claim 4 , wherein the seed oil extract comprises a perilla seed oil extract.6perilla frutescens. The composition according to claim 5 , wherein the perilla seed oil extract comprises a supercritical CO2 fluid extracted perilla seed oil extract derived from a cracked biomass of claim 5 , the seed oil comprising from 60 to 95 percent w/w of PUFAs in a ratio from 4:1 to 6:1 alpha-linolenic acid (ALA) to linolenic acid (LA).7. The composition according to claim 1 , wherein the composition includes the phospholipid rich egg roe extract supplemented with 0.1-12 mg ...

PERILLA EXTRACT COMPOSITION

Compositions and methods for use in inhibiting mast cell activation and/or treatment or prevention of disorders associated with mast cell activation or degranulation. The compositions and methods of use include a spp. extract, such as in combination with another plant extract. The second plant extract desirably adds anti-inflammatory and/or anti-allergy properties to the compositions. 130-. (canceled)31Perilla. A composition comprising a spp. extract and another plant extract.32. The composition of claim 31 , wherein the other plant extract is an anti-inflammatory and/or an anti-allergic plant extract.33NigellaUrticaAstragalusPetasitesCitrusUncariaLavandulaMenthaEucalyptusMatricariaRosmarinusCurcumaAlliumSesamum. The composition of claim 31 , wherein the other plant extract is derived from spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. or spp.34Sesamum. The composition of claim 31 , wherein the other plant extract is derived from spp.35Perilla. The composition of claim 31 , wherein the spp. extract and/or the other plant extract is each claim 31 , independently claim 31 , obtained from the seed claim 31 , root claim 31 , leaf or whole of the plant.36Perilla. The composition of claim 31 , wherein the spp. extract and/or the other plant extract is each claim 31 , independently claim 31 , an oil.37Perillaperilla. The composition of claim 31 , wherein the spp. extract is oil and the other plant extract is sesame oil.38Perilla. The composition of claim 31 , wherein the spp. extract and the other plant extract are present in the composition in a weight ratio ranging from about 1:10 to about 10:1.39. The composition of claim 31 , wherein the composition comprises a tablet claim 31 , capsule claim 31 , caplet claim 31 , drageé claim 31 , lozenge claim 31 , granule claim 31 , powder claim 31 , pellet claim 31 , bead claim 31 , ...

A COMPOSITION HAVING A PREBIOTIC EFFECT

Provided are food, dietary supplements and/or drug compositions having prebiotic effect and their use in human and animal care. 1BacteroidesPerillaBacteroides. A method of promoting growth of probiotic bacteria in a subject and/or inhibiting the growth of pathogenic bacteria selected from the group consisting of Enterobacteriaceae , and/or Clostridia in a subject , the method comprising administering to the subject a prebiotic composition comprising a preparation in an amount effective to promoting growth of probiotic bacteria in a subject as a prebiotic and/or inhibiting the growth of pathogenic bacteria selected from the group consisting of Enterobacteriaceae , and/or Clostridia.2Perilla. The method according to claim 1 , wherein the preparation is a extract.3Perilla frutescensPerilla ocymoides. The method according to claim 1 , wherein the preparation is a or preparation.4. The method according to claim 1 , wherein the probiotic bacteria is selected from the group consisting of Bifidobacteria and Lactobacilli.5Lactobacillus bulcaricus, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium lactisBifidobacterium longum.. The method according to claim 4 , wherein the probiotic bacteria is selected from the group consisting of and6Perilla. The method according to wherein the preparation has a neutral effect to the growth of pathogenic bacteria.7Perilla. The method according to claim 1 , wherein the preparation neutralizes pathogenic bacteria.8Perilla. The method according to wherein the preparation inhibits the growth of pathogenic bacteria.9Bacteroides. The method according to claim 1 , wherein the pathogenic bacteria are selected from the group consisting of Enterobacteriaceae claim 1 , and Clostridia.10Salmonella typhimurium, Escherichia coliEnterobacter cloacae.. The method according to claim 9 , wherein the pathogenic bacteria are selected from the group ...

EYE HEALTH COMPOSITION AND METHOD USING PLANT DERIVED SEED EXTRACT RICH IN ESSENTIAL FATTY ACIDS DERIVED FROM PERILLA SEED AND CAROTENOIDS

A dietary supplement composition is formulated in a therapeutically effective amount to treat the eye of an individual. The composition includes a seed oil extract, astaxanthin, and at least one carotenoid selected from the group consisting of lutein, trans-zeaxanthin and meso-zeaxanthin. 1perilla. A dietary supplement composition formulated in a therapeutically effective amount to treat the eye of an individual , comprising a seed oil extract , astaxanthin , and at least one carotenoid selected from the group consisting of lutein , trans-zeaxanthin and meso-zeaxanthin.2. The composition according to claim 1 , further comprising 0.5 to 8 mg of astaxanthin claim 1 , 2 to 15 mg of lutein and 0.2 to 12 mg of trans-zeaxanthin on a daily basis.3. The composition according to claim 2 , comprising about 4 mg of astaxanthin claim 2 , about 10 mg of lutein and about 1.2 mg of trans-zeaxanthin.4perilla. The composition according to claim 1 , comprising about 50 to 500 mg of seed oil extract on a daily basis.5. The composition according to claim 1 , wherein the dietary supplement composition is formulated into a single dosage capsule.6Haematococcus pluvialis.. The composition according to claim 1 , wherein the astaxanthin comprises 3S claim 1 ,3′S-astaxanthin derived from7Haematococcus pluvialisHaematococcus pluvialisperillaperillaperilla. The composition according to claim 1 , comprising 3S claim 1 , 3′S-astaxanthin derived from claim 1 , lutein and trans-zeaxanthin claim 1 , wherein the 3S claim 1 ,3′S-astaxanthin derived from is 0.1 to 16 percent by weight of the seed oil extract claim 1 , the lutein is 0.4 to 30 percent by weight of the seed oil extract claim 1 , and the trans-zeaxanthin is 0.04 to 24 percent by weight of the seed oil extract in an oral dosage form.8perilla. The composition according to claim 1 , comprising krill oil supplemented to the seed oil extract.9perilla. The composition according to claim 1 , comprising an algae based oil supplemented to the seed ...

Acne Solution

A composition for the treatment of acne includes hydrolyzed Psoralea Corylifolia , containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

Nutritional Composition for Protecting Liver and Method for Preparing the Same

The present application discloses a nutritional composition for protecting liver. The nutritional composition comprises the following components of raw materials in parts by weight: indica rice 60-83, polished round-grained rice 11-29, lycium barbarum 1-4, finger citron 1.5-5, citron 0.05-0.2, and Chinese date 1-3.5. The present invention, in view of the liver's characteristics of preferring free activity and disliking depression, complies with the liver's physiological function characteristics for regulation, and provides the prescription based on the method of nourishing yin blood so as to disinhibit the liver, and it is suitable to cooperate with staple foods for long-term consumption, is easily accepted by people due to the good taste, and can achieve certain efficacies of soothing the liver and nourishing the liver.

SOLID DRINK FOR REGULATING YANG-DEFICIENCY CONSTITUTION AND PROCESSING METHOD THEREOF

Provided is a solid drink for regulating yang-deficiency constitution. The solid drink includes the following components of raw materials in parts by weight: 30-60, raspberry 35-55, barbarum 35-57, poria 30-54, cinnamon 35-55, fennel 20-40, ginger 33-55, dextrin 50-90, maltodextrin 23-45, soluble starch 20-44, and aspartame 0.15-0.35. The solid drink is easy to manufacture, and all the raw materials used are medicine materials of medicinal and edible dual purposes, and all the excipients used also satisfy national standard GB2760-2011 (National Food Safety Standard for Uses of Food Additives). It is safe to eat (drink) with good taste, and long-term consumption has certain effects on improving the yang-deficiency constitution. Moreover, the processing process is suitable for industrial mass production. 1perilla, lycium. A solid drink for regulating yang-deficiency constitution , comprising the following components of raw materials in parts by weight: 30-60 , raspberry 35-55barbarum 35-57 , poria 30-54 , cinnamon 35-55 , fennel 20-40 , ginger 33-55 , dextrin 50-90 , maltodextrin 23-45 , soluble starch 20-44 , and aspartame 0.15-0.35.2perilla, lycium. The solid drink for regulating yang-deficiency constitution of claim 1 , comprising the following components of raw materials in parts by weight: 40-50 claim 1 , raspberry 41-49barbarum 39-51 claim 1 , poria 38-47 claim 1 , cinnamon 41-52 claim 1 , fennel 25-35 claim 1 , ginger 37-50 claim 1 , dextrin 60-80 claim 1 , maltodextrin 27-40 claim 1 , soluble starch 25-39 claim 1 , and aspartame 0.2-0.3.3perilla, lycium. The solid drink for regulating yang-deficiency constitution of claim 1 , comprising 45 claim 1 , raspberry 45barbarum 45 claim 1 , poria 45 claim 1 , cinnamon 45 claim 1 , fennel 30 claim 1 , ginger 45 claim 1 , dextrin 69 claim 1 , maltodextrin 34 claim 1 , soluble starch 34 claim 1 , and aspartame 0.25.4. A method for processing a solid drink for regulating yang-deficiency constitution claim 1 , comprising ...

Solid Beverage for Conditioning Allergic Constitution and Method for Producing the Same

The present application discloses a solid beverage for conditioning allergic constitution. The solid beverage comprises the following components in parts by weight: 18-45 parts of smoked plum, 10-30 parts of , 18-45 parts of , 10-30 parts of purslane, 10-30 parts of seed, 10-30 parts of semen hoveniae, 7-20 parts of dahurian , 15-40 parts of dextrin, 9-23 parts of maltodextrin, 9-23 parts of soluble starch and 0.1-0.3 parts of aspartame. The solid beverage of the present application is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, and has certain effects on the improvement of allergic constitution, and the production process thereof is suitable for industrial mass production. 1perilla,lilium brownii,coixangelica,. A solid beverage for conditioning allergic constitution , characterized by comprising the following components in parts by weight: 18-45 parts of smoked plum , 10-30 parts of 18-45 parts of 10-30 parts of purslane , 10-30 parts of seed , 10-30 parts of semen hoveniae , 7-20 parts of dahurian 15-40 parts of dextrin , 9-23 parts of maltodextrin , 9-23 parts of soluble starch and 0.1-0.3 parts of aspartame.2perilla,lilium brownii,coixangelica,. The solid beverage for conditioning allergic constitution according to claim 1 , characterized by comprising the following components in parts by weight: 25-35 parts of smoked plum claim 1 , 10-22 parts of 23-30 parts of 18-30 parts of purslane claim 1 , 13-25 parts of seed claim 1 , 15-26 parts of semen hoveniae claim 1 , 11-17 parts of dahurian 19-33 parts of dextrin claim 1 , 13-18 parts of maltodextrin claim 1 , 11-17 parts of soluble starch and 0.13-0.22 parts of aspartame.3perilla,lilium brownii,coixangelica,. The solid beverage for ...

Solid Drink for Regulating Phlegm-dampness Constitution and Processing Method thereof

A solid drink includes the following components of raw materials in parts by weight: kudzu vine root 25-60 parts, nutmeg 13-35 parts, 30-50 parts, radish seed 34-53 parts, dried tangerine peel 28-55 parts, poria 27-52 parts, 4-15 parts, malt 26-50 parts, 14-33 parts, kelp 24-51 parts, 22-40 parts, dextrin 50-90 parts, maltodextrin 38-70 parts, soluble starch 35-70 parts, and aspartame 0.1-0.5 parts. 1fructus perillaefructus amomiagastache rugosasemen coicis. A solid drink for regulating phlegm-dampness constitution , comprising kudzu vine root 25-60 parts by weight , nutmeg 13-35 parts by weight , 30-50 parts by weight , radish seed 34-53 parts by weight , dried tangerine peel 28-55 parts by weight , poria 27-52 parts by weight , 4-15 parts by weight , malt 26-50 parts by weight , 14-33 parts by weight , kelp 24-51 parts by weight , 22-40 parts by weight , dextrin 50-90 parts by weight , maltodextrin 38-70 parts by weight , soluble starch 35-70 parts by weight , and aspartame 0.1-0.5 parts by weight.2fructus perillaefructus amomiagastache rugosasemen coicis. The solid drink of claim 1 , wherein claim 1 , the kudzu vine root is 30-50 parts by weight claim 1 , the nutmeg is 18-30 parts by weight claim 1 , the is 35-45 parts by weight claim 1 , the radish seeds are 37-49 parts by weight claim 1 , the dried tangerine peel is 33-46 parts by weight claim 1 , the poria is 33-45 parts by weight claim 1 , the is 6-11 parts by weight claim 1 , the malt is 32-46 parts by weight claim 1 , the is 17-29 parts by weight claim 1 , the kelp is 31-47 parts by weight claim 1 , the is 29-36 parts by weight claim 1 , the dextrin is 60-80 parts by weight claim 1 , the maltodextrin is 45-63 parts by weight claim 1 , the soluble starch is 45-63 parts by weight claim 1 , and the aspartame is 0.2-0.4 parts by weight.3fructus perillaefructus amomiagastache rugosasemen coicis. The solid drink of claim 1 , wherein claim 1 , the kudzu vine root is 40 parts by weight claim 1 , the nutmeg is 24 ...

Chinese Herbal Oral Paste for Conditioning Qi Depression Constitution and Processing Method therefor

The present application discloses a Chinese herbal oral paste for conditioning qi depression constitution. The Chinese herbal oral paste includes the following components: Chinese thorowax root, debark peony root, licorice, Sichuan lovage rhizome, dried tangerine peel, orange fruit, nutgrass galingale rhizome, mint, fuling, perilla leaf, largehead atractylodes rhizome, fruit of caoguo, common aucklandia root, chinaberry fruit, lychee seed, finger citron, citron fruit, rose flower, citrus aurantium L, silktree albizia bark, nardostachys root, grassleaf sweetflag rhizome, heterophylly falsestarwort root, Chinese yam, white hyacinth bean, dendrobium, turmeric root tuber, donkey-hide gelatin, turtle shell gelatin, tortoise-plastron gelatin, and xylitol. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the qi depression constitution, will not create negative effects to the human body at all, and is capable of achieving certain efficacy of strengthening physical health.

Anti-Acne Formulation

A composition for the treatment of acne includes hydrolyzed containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution. 1. A method of preparing an aqueous mixture comprising:providing a first mixture, wherein the first mixture is uniformly mixed, is aqueous, and at a temperature of about 40 to about 45 degrees Celsius;{'i': 'Psoralea corylifolia', 'providing an unsolubilized hydrolyzed extract; and'}{'i': 'Psoralea corylifolia', 'solubilizing the unsolubilized hydrolyzed extract comprising{'i': 'Psoralea corylifolia', 'mixing the unsolubilized hydrolyzed extract, bisabolol, and polysorbate 20 at room temperature to obtain a second mixture, and'}{'i': 'Psoralea corylifolia', 'adding the second mixture to the first mixture to obtain a third mixture, wherein the third mixture is at a temperature below about 40 to about 45 degrees Celsius, and the third mixture is an aqueous mixture comprising a solubilized hydrolyzed extract.'}2. A method of preparing an aqueous mixture comprising:mixing first contituents to obtain a first mixture, wherein the first mixture is provided at a temperature of 45 degrees or greater;{'i': Psoralea corylifolia', 'Psoralea corylifolia', 'Psoralea corylifolia', 'Psoralea corylifolia, 'solubilizing an unsolubilized hydrolyzed extract to obtain a solubilized hydrolyzed extract comprising mixing the unsolubilized hydrolyzed extract and bisabolol to obtain a second mixture, and adding the second mixture to the first mixture at a ...

PLANT DERIVED SEED EXTRACT RICH IN ESSENTIAL FATTY ACIDS DERIVED FROM PERILLA SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE

A composition of matter comprises a shelf stable, super critical, COfluid extracted seed oil derived from a cracked biomass of , the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants. 1perilla frutescensperilla frutescens. A composition of matter comprising a fractionated , shelf stable , supercritical , COfluid extracted heavy fraction seed oil derived from a cracked biomass of , and made by the process of fractionating a supercritical fluid COextracted seed oil , and separating a heavy fraction from a light fraction to form the final seed oil from the heavy fraction , the seed oil comprising from 60 to 95 percent w/w of PUFAs in a ratio of from 4:1 to 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and comprising a mixture of selected antioxidants.2. The composition of matter according to claim 1 , wherein the selected antioxidants comprise a mixture of selected lipophilic and hydrophilic antioxidants.3. The composition of matter according to claim 1 , and further comprising lipophilic antioxidants either alone or in combination with at least one of: a) phenolic antioxidants including at least one of sage claim 1 , oregano claim 1 , and rosemary; b) tocopherol claim 1 , c) tocotrienol(s) claim 1 , d) carotenoids including at least one of astaxanthin claim 1 , lutein claim 1 , and zeaxanthin; e) ascorbylacetate; f) ascorbylpalmitate g) Butylated hydroxytoluene (BHT); h) Docosapentaenoic Acid (BHA) or i) Tertiary Butyl hydroquinone (TBHQ).4. The composition of matter according to claim 1 , and further comprising a hydrophilic antioxidant or sequesterant comprising hydrophilic phenolic antioxidants including at least one of grape seed extract claim 1 , tea extracts claim 1 , ascorbic acid claim 1 , citric acid claim 1 , tartaric acid claim 1 , and malic acid.5. The composition of matter according to claim 1 , wherein ...

Extracts of perilla frutescens seeds and their pharmaceutical uses

Disclosed is an extract of Perilla frutescens seeds that contains rosmarinic acid, luteolin, and apigenin, the weight ratio between rosmarinic acid, luteolin, and apigenin being 0.1-200:0.1-200:1. Also disclosed is a method for treating a psychiatric disorder using the above-described extract or an extract of Perilla frutescens seeds containing at least an active agent selected from the group consisting of rosmarinic acid, luteolin, and apigenin.

COMPOSITION USING SEED OIL EXTRACTS AND PHOSPHOLIPIDS TO ENHANCE ABSORPTION OF CAROTENOIDS AND ASSOCIATED METHODS

A dietary supplement composition is formulated in a therapeutically effective amount to treat the eye of an individual having an eye impairment, including dry eyes. It includes a mixture of a phospholipid and a seed oil extract having an ALA to LA ratio between 1:1 and 6:1, astaxanthin, and at least one carotenoid selected from the group consisting of lutein, trans-zeaxanthin, and meso-zeaxanthin. It is formulated into a single dosage capsule. 1. A dietary supplement composition formulated in a therapeutically effective amount to treat the eye of an individual having an eye impairment comprising a mixture of a phospholipid and a seed oil extract having an alpha-linolenic acid (ALA) to linoleic acid (LA) ratio between 1:1 and 6:1 , astaxanthin , and at least one carotenoid selected from the group consisting of lutein , trans-zeaxanthin and meso-zeaxanthin , and formulated into a single dosage capsule.2. The dietary supplement composition according to claim 1 , wherein the phospholipid comprises a phospholipid rich egg roe extract comprising at least 50 percent phospholipids.3. The dietary supplement composition according to claim 1 , wherein the phospholipid comprises at least one of Phosphatidylcholine claim 1 , Phosphatidylethanolamine claim 1 , Phosphatidylserine claim 1 , Phosphatidylinositol claim 1 , Phosphatidic acid claim 1 , Lyso-Phosphatidylcholine claim 1 , Lyso-Phosphatidylethanolamine claim 1 , and Lyso-Phosphatidylserine.4. The dietary supplement composition according to claim 1 , wherein the phospholipid is derived from at least one of a plant claim 1 , algae and animal source or synthetic derivative.5. The dietary supplement composition according to claim 1 , comprising a mixture of antioxidants admixed with the phospholipid and seed oil extract.6. The dietary supplement composition according to claim 1 , wherein the astaxanthin is derived from a natural or synthetic ester or synthetic dial.7perilla frutescens. The dietary supplement composition ...

COMPOSITION COMPRISING VICENIN-2 HAVING A BENEFICIAL EFFECT ON NEUROLOGICAL AND/OR COGNITIVE FUNCTION

The invention relates to an active ingredient and/or to a composition having beneficial effect on neurological and cognitive functions. 1. A method of maintaining and/or improving neurological and/or brain function and/or preventing , delaying onset , controlling and/or treating a neurological dysfunction , condition , disorder or disease , the method comprising administering vicenin 2 or a biologically active analogue thereof as an active ingredient to a subject in need thereof.2. The method of claim 1 , for maintaining and/or improving neurological and/or brain function.3. The method of claim 1 , wherein the neurological dysfunction claim 1 , condition claim 1 , disorder or disease is an age or stress related neurological dysfunction claim 1 , anxiety claim 1 , a cognitive disorder claim 1 , depression or dementia.4. The method of claim 1 , wherein the active ingredient is derived from a plant.5. The method of claim 4 , wherein the active ingredient is comprised in a plant preparation enriched for the active ingredient.6Anethum, Perilla, Urtica, Passiflora, Camelia, Cayaponia, Colocasia, Cydonia, Desmodium, Hordeum, Origanum, Ocimum, Jatropha, Parkinsonia, Peperomia, Piheranthos, Centaurea, Indigo, Bomba, Lychnophera, Asplenium, Chinotto, Citrus, Viola, Trigonella, Rosemary, Peppermint, Thyme, Basil, Sage, Oregano, Lavandula, Nipponanthemum, Abrus, Viola, Santalum, Oryza, Scleropyrum, Tulsi, Centaurea, Indigofera, Bombax, Glinus, Lychnophora. The method of claim 4 , wherein the plant is selected of one or more plants from a group consisting of a claim 4 , other species belonging to the Lamiacea claim 4 , Labiatae claim 4 , and Urticaceae claim 4 , Rosales or Malpighiales or a combination thereof.7. The method of claim 1 , wherein the active ingredient is derived from a plant preparation selected from the group consisting of a leaf preparation claim 1 , a fruit preparation claim 1 , a seed preparation claim 1 , a stem preparation claim 1 , a flower preparation ...

ORAL LIQUID FOR TREATING ALLERGIC COUGH

A medicine for treating allergic cough comprises 5 to 25 parts by weight of Leaf, 5 to 25 parts by weight of Periostracum Cicada, and 5 to 25 parts by weight of . The medicine is in the form of concentrated decoction, tablet, pill, granule or capsule. The medicine has effects of dispelling wind-cold, dispelling wind-heat, relieving cough and preventing asthma. The medicine provides excellent anti-allergic effect and can be used for treating allergic cough. 1. An oral liquid for treating allergic cough , comprising:{'i': 'Perilla', '5 to 25 parts by weight of Leaf;'}5 to 25 parts by weight of Periostracum Cicada; and{'i': 'lumbricus;', '5 to 25 parts by weight of'}wherein the oral liquid is a concentrated decoction.2Stemonae,phragmitesFlos Farfarae,Bulbus Fritillariae CirrhosaeExocarpium Citri Rubrum.. The oral liquid for treating allergic cough of claim 1 , further comprising 5 to 25 parts by weight of Radix Peucedani claim 1 , 5 to 25 parts by weight of Radix 5 to 25 parts by weight of stem claim 1 , 5 to 25 parts by weight of 5 to 25 parts by weight of claim 1 , and 5 to 25 parts by weight of3Perillalumbricus,Stemonae,phragmitesFlos Farfarae,Bulbus Fritillariae CirrhosaeExocarpium Citri Rubrum.. The oral liquid for treating allergic cough of claim 2 , comprising 10 to 20 parts by weight of Leaf claim 2 , 10 to 20 parts by weight of Periostracum Cicada claim 2 , 10 to 20 parts by weight of 10 to 20 parts by weight of Radix Peucedani claim 2 , 10 to 20 parts by weight of Radix 10 to 20 parts by weight of stem claim 2 , 10 to 20 parts by weight of 10 to 20 parts by weight of claim 2 , and 10 to 20 parts by weight of4. The oral liquid for treating allergic cough of claim 1 , wherein the oral liquid is used for preparing a medicine for treating allergic cough.5. A pharmaceutical preparation for treating allergic cough claim 1 , comprising:{'i': 'Perilla', '5 to 25 parts by weight of Leaf;'}5 to 25 parts by weight of Periostracum Cicada; and{'i': 'lumbricus;', '5 to 25 ...

A NASAL COMPOSITION

The present invention relates to a nasal composition comprising an anti-allergic oil derived from plant; and an oil-based barrier-forming preparation. The composition may be used in preventing and/or treating allergic disorders of the nasal cavity, including seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis. 1. A nasal composition comprising:an anti-allergic oil derived from plant; andan oil-based barrier-forming preparation.2PerillaNigellaUrticaAstragalusPetasitesCitrusUncariaLavandulaMenthaEucalyptusMatricariaRosmarinusCurcumaAllium. A nasal composition according to claim 1 , wherein the anti-allergic oil is derived from the plant of spp. claim 1 , spp. claim 1 , spp. spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , or a combination of any two or more thereof.3. A nasal composition according to claim 2 , wherein the anti-allergic oil is obtained from the seed claim 2 , root claim 2 , leaf claim 2 , or whole plant parts of the plant.4. A nasal composition according to claim 1 , wherein the oil-based barrier-forming preparation contains an oily component claim 1 , one or more gel formers and an aqueous base.5. A nasal composition according to claim 4 , wherein the oily component is a hydrocarbon claim 4 , a plant oil claim 4 , a vegetable oil or hydrated claim 4 , polyoxyethylated or polyoxy- or hydrated polyoxy or fractionated derivatives thereof claim 4 , or a combination of any two or more thereof.6PerillaNigella. A nasal composition according to claim 4 , wherein the oily component is sesame oil claim 4 , and/or wherein the anti-allergic oil is derived from the plant of spp. and/or spp.7. A nasal composition according to claim 1 , wherein the anti-allergic oil and the oily component is present in a weight ratio range of about 1:10 to 10:1.8. A nasal composition according to claim 4 , wherein the one or more gel formers are for ...

PHARMACEUTICAL COMPOSITION FOR ALLEVIATING EYE FATIGUE, CONTAINING, AS ACTIVE INGREDIENTS, LUTEOLIN-7-O-DIGLUCURONIDE AND APIGENIN-7-O-DIGLUCURONIDE ISOLATED FROM PERILLA FRUTESCENS (L.) BRITTON VAR. ACUTA (THUNB.) KUDO LEAF EXTRACT

The present invention, it was confirmed that a pharmaceutical composition and a health functional food composition for alleviating eye fatigue containing, as active ingredients, compounds, particularly, luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide isolated from a (L.) Britton var. (Thunb.) Kudo leaf extract have an effect of alleviating eye fatigue by increasing the contents of NO and cGMP associated with relaxation of ciliary smooth muscle cells isolated from rat's eyes and decreasing the content of [Ca]i, and increasing cGMP which is a factor associated with relaxation of the ciliary smooth muscle through an animal experiment. As a result, the luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds extracted from (L.) Britton var. (Thunb.) Kudo may be usefully used as a pharmaceutical composition and a health functional food composition having an eye fatigue alleviating effect as a Korean natural resource. 1Perilla frutescensacuta. A pharmaceutical composition for preventing and alleviating eye fatigue containing , as active ingredients , luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds obtained from a (L.) Britton var. (Thunb.) Kudo leaf extract.2Perilla frutescensacuta. The pharmaceutical composition for preventing and alleviating eye fatigue of claim 1 , wherein the luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds are isolated and purified by freeze-drying or spray-drying the (L.) Britton var. (Thunb.) Kudo leaf extract.3Perilla frutescensacuta. The pharmaceutical composition for preventing and alleviating eye fatigue of claim 1 , wherein the luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds are isolated and purified from a water extract of (L.) Britton var. (Thunb.) Kudo leaves.4Perilla frutescensacuta. The pharmaceutical composition for preventing and alleviating eye fatigue of claim 3 , wherein the compounds are isolated and purified by adding the water extract of (L.) Britton ...

COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING PHOSPHOLIPIDS AND ROE EXTRACT

A dietary supplement composition and associated method has its composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) having a molecular weight of 0.5 to 300 kilodaltons (kDa), and a phospholipid rich egg roe extract having phospholipid bound EPA and DHA admixed with seed and/or fish oil having an ALA to LA ratio of 1:1 to 6:1 and in an oral dosage form. 1. A method to treat and alleviate symptoms of joint pain in a person having joint pain by administering to a person a therapeutic amount of a dietary supplement composition comprising astaxanthin , low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) having a molecular weight of 0.5 to 300 kilodaltons (kDa) , and a phospholipid rich egg roe extract admixed with seed oil having an alpha-linolenic acid (ALA) to linoleic acid (LA) ratio of 1:1 to 6:1 and in an oral dosage form.2. The method according to claim 1 , wherein the phospholipid rich egg roe extract admixed with seed oil contains phospholipid bound EPA and DHA.3. The method according to claim 1 , wherein the low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) comprises pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments.4. The method according to claim 1 , wherein the low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) has a molecular weight of 0.5 to 100 kDa.5. The method according to claim 1 , wherein the phospholipid rich egg roe extract admixed with seed oil comprises about 15 to about 60 percent phospholipids.6. The method according to claim 1 , wherein the phospholipid rich egg roe extract admixed with seed oil comprises Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids wherein the amount of DHA is at least 50 percent greater than the amount of EPA.7. The method according to ...

COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERB CONSISTING OF HEAT PROCESSED GINSENG, HOUTTUYNIAE HERBA, PERILLA LEAF AND TEA LEAF OR THE PROCESSED EXTRACT THEREOF AS AN ACTIVE INGREDIENT SHOWING HAIR-STIMULATING ACTIVITY AND PREVENTING ACTIVITY FROM HAIR LOSS, AND THE USE THEREOF.

The present invention relates to a composition comprising the extract of combined herbs consisting of heat processed , houttuyniae herba, leaf and tea leaf or the processed extract thereof as active ingredients for preventing and treating hair baldness and stimulating activity of hair growth. The inventive combined extract showed more potent hair-growth promoting activity and synergistic effect than the precedent invention(s), for example, a fermented extract of Houttuyniae Herba, leaf and Tea leaf disclosed in Korea Patent Publication No, 10-2014-0114492 (A1), through various animal model experiments such as the growth rate test using by C57BL/6 mouse, the proliferating effect on the growth of HFDPC etc and additionally, more favorable advantage than the precedent invention(s), for example, the easiness in controlling the prescribed dosage by dint of the final form of the inventive extract, i.e., concentrated solid form comparing with the solution type of the final form disclosed in precedent invention. 1ginsengperilla. A pharmaceutical composition for treating hair baldness and stimulating activity of hair growth comprising an extract of heat processed , houttuyniae herba , leaf and tea leaf , or a processed extract thereof.2ginsengginsengginsengginsengPanax ginseng, Panax quinquefolius, Panax notoginseng, Panax japonica, Panax trifolia, Panax pseudoginseng, Panax vietnamensis, Panax elegatior, Panax wangianusPanax bipinratifidus.. The pharmaceutical composition according to claim 1 , wherein said heat processed is selected from the group consisting of root claim 1 , leaf claim 1 , fruit claim 1 , and rhizome of a red or the processed produced by heating at a temperature ranging from 80 to 200° C. for a period ranging from 0.5 to 78 hours claim 1 , so as to make a ratio of ginsenoside (Rg3+Rg5+Rk1) to (Rb1+Rb2+Rc+Rd) of over 1.0 claim 1 , wherein the red is selected from the group consisting of and3. The pharmaceutical composition according to claim 1 , wherein ...

COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF ALLERGY SYMPTOMS

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. In particular, the composition according to the invention comprises at least one slow release component comprising quercetin and at least one fast release component comprising an extract from or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechina, ferulic acid, caffeic acid or mixtures thereof, The invention further comprises the use of the composition in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. 1. Composition comprising:at least one slow release component comprising quercetin; and{'i': 'Perilla frutescens', 'at least one fast release component comprising an extract from or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechin, ferulic acid, caffeic acid or mixture thereof.'}2. Composition according to claim 1 , wherein quercetin is in the form of its glucosides and/or its salts.3Sophora JaponicaDimorphandra mollis,Sophora Japonica.. Composition according to claim 1 , wherein quercetin derives from or preferably4. Composition according to claim 1 , wherein quercetin is in a percentage from 1% to 70% claim 1 , where each % is referred to the total weight of the composition.5. Composition according to claim 1 , wherein quercetin is in the composition in an amount from 50 mg to 1000 mg.6perilla frutescens. Composition according to claim 1 , wherein the extract is water-soluble.7perilla frutescensPerilla frutescens.. Composition according to claim 1 , wherein the extract derives from leafs or seeds of8perilla frutescens. Composition according to claim 1 , wherein the extract is in a percentage from 1% to 50% claim 1 , where each % is referred to the total weight of the composition.9perilla ...

ANTI-INFLAMMATORY COMPOSITION AND COMPOSITION FOR TREATMENT OF INFLAMMATORY DISEASE, BOTH COMPRISING COMPOSITE PLANT EXTRACT

The present invention relates to an anti-inflammatory composition and a composition for treatment of an inflammatory disease, both comprising a composite plant extract and, more particularly, to an anti-inflammatory composition comprising a composite plant extract including a extract and an Koidzumi extract; a preparation method thereof; and a pharmaceutical composition comprising the composite extract for treatment of an inflammatory disease. 1Perilla frutescensAtractylodes japonica. An anti-inflammatory composition comprising a phyto-extract mixture including a Britt. extract and an Koidz. extract.2Perilla frutescens. The anti-inflammatory composition according to claim 1 , wherein the Britt. extract comprises isoegomaketone (IK) or a salt of the isoegomaketone (IK) as an active ingredient.3Perilla frutescens. The anti-inflammatory composition according to claim 1 , wherein the Britt. is Antisperill (KCTC 13077BP).4Perilla frutescens. The anti-inflammatory composition according to claim 3 , wherein the Britt. extract has an isoegomaketone (IK) content of 10 mg to 30 mg per 1 g of extract claim 3 , and an isoegomaketone (IK) concentration of 100 mg/mL to 300 mg/mL.5Perilla frutescensAtractylodes japonica. The anti-inflammatory composition according to claim 1 , wherein the Britt. extract and the Koidz. extract are extracts obtained by alcohol extraction using an ethanol solvent claim 1 , respectively.6Perilla frutescensAtractylodes japonica. The anti-inflammatory composition according to claim 1 , wherein the Britt. extract and the Koidz. extract are extracts obtained by supercritical extraction claim 1 , respectively.7. The anti-inflammatory composition according to claim 1 , wherein the phyto-extract mixture further comprises an alcohol extract by an ethanol solvent of Acanthopanaxsenticosus.8Perilla frutescensAtractylodes japonica. The anti-inflammatory composition according to claim 7 , wherein the phyto-extract mixture is formed as the other two extracts for 1 ...

Pharmaceutical compositions for treating cancer of genital system and preparation method therefor

A pharmaceutical composition for preventing and treating cancer of reproductive system and preparation method therefor. The pharmaceutical composition is prepared using one or more of the following as raw material: tuber, bighead tuber, liquorice root, Indian bread, white peony root, fresh ginger. 1. A pharmaceutical composition for treating cancer of genital system caused by fungus , characterized in that it comprises crude drugs of following weight: 1˜50 dosages of pinelliaternate , 1˜50 dosages of atractylodes macrocephala , 1˜50 dosages of gastrodia elata Bl , 1˜50 dosages of licorice , 1˜50 dosages of poria cocos , and 1˜50 dosages of fructus aurantli irnmaturus.2. A pharmaceutical composition for treating fungus claim 1 , bacillus claim 1 , virus and other anaerobic bacteria and preventing cancer of genital system according to claim 1 , characterized in that it comprises crude drugs of following weight: 1˜50 dosages of pinelliaternate claim 1 , 1˜50 dosages of atractylodes macrocephala claim 1 , 0˜51 dosages of gastrodia elata Bl claim 1 , 1˜50 dosages of licorice claim 1 , 0˜50 dosages of poria cocos claim 1 , 0˜50 dosages of white paeony root claim 1 , 0˜50 dosages of tangerine peel claim 1 , 0˜50 dosages of ginger claim 1 , 1˜50 dosages of radix sileris claim 1 , 1˜50 dosages of herba schizonepetae claim 1 , 0˜50 dosages of perilla claim 1 , 0˜50 dosages of bupleurum and 0˜50 dosages of radix scutellariae.3. A pharmaceutical composition for preventing cancer of reproductive system caused by fungus according to claim 1 , characterized in that it comprises crude drugs of following weight: 1˜50 dosages of pinelliaternate claim 1 , 1˜50 dosages of atractylodes macrocephala claim 1 , 1˜50 dosages of gastrodia elata Bl claim 1 , 1˜50 dosages of rhizoma corydalis claim 1 , 1˜50 dosages of rhizoma cyperi claim 1 , 1˜50 dosages of costustoot claim 1 , 1˜50 dosages of licorice claim 1 , 1˜50 dosages of angelica sinensis claim 1 , 1˜50 dosages of poria cocas claim 1 , ...

THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD

A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments. 1Haematococcus pluvialis. A dietary supplement composition formulated in a therapeutic effective amount to treat low density lipoprotein (LDL) peroxidation in humans composition comprising 0.5 to 12 mg of astaxanthin derived from (Hp) , and 50 to 500 mg of a lipid selected from the group consisting of a phospholipid , glycolipid , and sphingolipid , wherein the astaxanthin is 0.1 to 15 percent by weight of the lipid selected from the group consisting of a phospholipid , glycolipid and sphingolipid , and wherein the composition is formulated into an oral dosage form as a single dosage capsule.2. The composition according to claim 1 , wherein the composition further comprises a pharmaceutical or food grade diluent.3. The composition according to claim 1 , wherein the phospholipid is selected from the group consisting of Phosphatidylcholine claim 1 , Phosphatidylethanolamine claim 1 , Phosphatidylserine claim 1 , Phosphatidylinositol claim 1 , Phosphatidic acid claim 1 , Lysophosphatidylcholine claim 1 , Lysophosphatidylethanolamine claim 1 , and Lysophosphatidylserine.4. The composition according to claim 1 , wherein the phospholipid comprises at least one of a plant claim 1 , algae and animal source derivative.5. The composition according to claim 1 , wherein the composition has the astaxanthin dispersed into the selected lipid under high shear conditions.6Haematococcus pluvialis. A dietary supplement composition formulated in a therapeutic ...

COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF ALLERGY SYMPTOMS

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. 1. Composition comprising:at least one slow release component comprising quercetin; and{'i': 'Perilla frutescens', 'at least one fast release component comprising an extract from or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechin, acid, caffeic acid or mixture thereof.'}2. Composition according to claim 1 , wherein quercetin is in the form of its glucosides and/or its salts.3Sophora JaponicaDimorphandra mollis.. Composition according to claim 1 , wherein quercetin derives from or4. Composition according to claim 1 , wherein quercetin is in a percentage from 1% to 70% claim 1 , where each % is referred to the total weight of the composition.5. Composition according to claim 1 , wherein quercetin is in the composition in an amount from 50 mg to 1000 mg.6perilla. Composition according to claim 1 , wherein the extract is water-soluble.7perillaPerilla frutescens.. Composition according to claim 1 , wherein the extract derives from leafs or seeds of8perilla. Composition according to claim 1 , wherein the extract is in a percentage from 1% to 50% claim 1 , where each % is referred to the total weight of the composition.9perilla. Composition according to claim 1 , comprising an amount of extract from 5 mg to 500 mg.10. Composition according to claim 1 , wherein the slow release component comprises a fat-soluble compound claim 1 , selected from fatty acids C-C claim 1 , glycerides claim 1 , fatty alcohol C-Cand mixture thereof.11. Composition according to claim 1 , wherein the slow release component comprises at least one fat-soluble vitamin and/or at least one surfactant.12. Composition according to claim 1 , wherein the slow release component further comprises colecalciferol.13. Composition according to ...

METHODS OF DEGRADING AGEs AND USES THEREOF

The present invention provides methods of use of AGEs-degrading agents. The methods include anti-aging methods and methods of treating or reducing likelihood of diseases, aging of tissues, and hypofunction of tissues caused by AGEs. The AGEs-degrading agents contain at least one kind of plant extract obtained from peanut, rosemary, knotweed, leaf lettuce, sweet basil, thyme, spearmint, lemon balm, , or rhubarb. 1. A method of degrading Advanced Glycation End-products (AGEs) in a sample , comprising:{'i': 'perilla', 'adding an AGEs-degrading agent to the sample, the AGEs-degrading agent comprising at least one kind of plant extract obtained from a plant selected from the group consisting of peanut, rosemary, knotweed, leaf lettuce, basil, thyme, spearmint, lemon balm, , and rhubarb.'}2. The method according to claim 1 , wherein the AGEs-degrading agent comprises two or more kinds of the plant extracts.3. The method according to claim 2 , wherein the AGEs-degrading agent comprises claim 2 , among the above-described plant extracts claim 2 , at least one kind of plant extract obtained from a plant selected from the group consisting of rosemary claim 2 , basil claim 2 , thyme claim 2 , spearmint claim 2 , and lemon balm claim 2 , which also serve to enhance activity of oxidized protein hydrolase.4. The method according to claim 1 , further comprising adding an oxidized protein hydrolase activity enhancer to the sample claim 1 ,{'i': 'stevia, chrysanthemum', 'wherein the oxidized protein hydrolase activity enhancer comprises at least one kind of plant extract obtained from a plant selected from the group consisting of water chestnut, , savory, mugwort, and chestnut.'}5. The method according to claim 1 , further comprising adding an antioxidant to the sample claim 1 ,{'i': 'hibiscus', 'wherein the antioxidant comprises at least one kind of plant extract obtained from a plant selected from the group consisting of lemon balm, spearmint, savory, , rosemary, thyme, clove, ...

AGING INHIBITOR

An object of the present invention is to provide a senescence retarding agent that delays the onset of senescence symptoms and extends longevity, and is superior in safety. The senescence retarding agent of the present invention that achieves the object is characterized by containing a plant fermentation product as an active ingredient, the plant fermentation product being a mixture of the following: (a) a koji mold-fermented product of one or more kinds of beans and/or cereals selected from the group consisting of barley, black soybean, red rice, black rice, adzuki bean, adlay, Japanese millet, foxtail millet, and millet; (b) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of fruits selected from the group consisting of mikan (mandarin orange), grape, apple, yama-budo (crimson glory grape), peach, kaki (Japanese persimmon), , nashi (Japanese pear), watermelon, ume (Japanese apricot), fig, karin (Chinese quince), pumpkin, kumquat, yuzu (Chinese lemon), loquat, apricot, jujube, chestnut, matatabi (silvervine), and sumomo (Japanese plum); (c) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of root crops and/or potatoes selected from the group consisting of murasaki-imo (purple sweet potato), kikuimo (Jerusalem artichoke), carrot, onion, satsuma-imo (sweet potato), satoimo (taro), jinenzyo (Japanese yam), daikon (Japanese radish), akakabu (red turnip), gobo (burdock root), renkon (lotus root), yacon, yuri-ne (lily bulb), kuwai (arrowhead), ginger, garlic, and turmeric; (d) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of flowers and/or leaf vegetables selected from the group consisting of cabbage, shiso (), mulberry leaves, dokudami (Korean houttuynia), yomogi (wormwood), kumazasa (kuma bamboo grass), and dandelion; (e) a yeast- and/or lactic acid bacterium-fermented product of one or more kinds of seaweeds selected from the group consisting of kombu (sea tangle), wakame (), and ...

COMPOSITION CONTAINING PERILLA FRUTESCENS FERMENTED EXTRACT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF SLEEP DISORDER

A pharmaceutical composition, dietary supplement, or food containing a fermented extract is disclosed. The composition is useful for prevention or treatment of a sleep disorder. A composition or a fiber or fragrance composition containing a fermented extract is also disclosed. A method for treating sleep disorder employing the pharmaceutical composition, dietary supplement, food, or the fiber or fragrance composition is disclosed. 1Perilla frutescens.. A composition comprising a2Perilla frutescens.. The composition of claim 1 , wherein the fermented extract is extracted from any one or more sites selected from the group consisting of leaves claim 1 , stems claim 1 , flowers claim 1 , fruit claim 1 , and seeds of3. The composition of claim 1 , wherein the fermented extract is extracted with water claim 1 , a Cto Corganic solvent claim 1 , or a mixture thereof as a solvent claim 1 , and then fermented with a fermentation strain.4. The composition of claim 3 , wherein the fermentation strain comprises any one or more strains selected from the group consisting of bacillus claim 3 , lactobacillus claim 3 , and yeast.5BacillusBacillus subtilis, Bacillus thuringiensis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus stearothermophilus, Bacillus coagulans, Bacillus longum, Bacillus pumilus, Bacillus brevis, Bacillus circulansBacillus polymyxaLactobacillusLactobacillus acidophilus, Lactobacillus casei, Lactobacillus gasseri, Lactobacillus bulgaricus, Lactobacillus helveticus, Lactobacillus fermentum, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus rhamnosusLactobacillus salivariusSaccharomycesSaccharomyces cerevisiae, Saccharomyces uvarun, Saccharomyces ellipsoideus, Saccharomyces carlsbergensis, Saccharomyces sake, Saccharomyces coreanus, Saccharomyces lipolytica, Saccharomyces boulardiiSaccharomyces pastorianus.. The composition of claim 4 , wherein the bacillus is any one or more genus bacteria selected from the group ...

用于提高透明质酸产率的组合物及其制备方法

一种特别在表皮细胞或由该细胞组成的组织中提高透明质酸产率的组合物，其中含有一种唇形科植物提取物作为活性成分，及其制备方法。尤其是，提供一种可安全和直接涂敷于人体皮肤以保持类似青年人的正常功能的化妆品或药物的组合物。

一种治疗风寒感冒的鸡肉酱添加剂及其制备方法

本发明公开了一种可治疗风寒感冒的鸡肉酱添加剂，它主要是由藿香、麻黄、葛根、百部、藁本、紫苏叶、桂枝、生姜、羌活、金沸草按一定重量配比制备而成。本发明配方独特，具有温润肺气、散寒祛风、发表镇痛、化痰止咳的功能，治疗风寒感冒功效突出，无副作用。

一种用于产后洗发预防引起头风的中药配方及其制备方法

本发明涉及一种用于产后洗发预防引起头风的中药配方及其制备方法，包括以下重量份数的中药成分：川芎：30‑60份；麻黄：10‑30份；桂枝：30‑60份；紫苏：30‑60份；荆芥穗：30‑60份；防风：30‑60份；羌活：30‑60份；白芷：30‑60份；细辛：3‑10份；藁本：30‑60份；紫珠：30‑60份；当归：30‑60份，其制作方法包括以下步骤：(1)将所述中药成分全部按比例放入台式连续投料粉碎机中进行打粉，设定细度50目，制成粗粉；(2)将步骤(1)中打好粗粉的中药材分装到不织布袋中并密封封口；每次用于洗头时，将药包放进药锅中加水熬煮，放至适温即可用于洗头发，本发明经多年临床实践研发出能固护卫表、袪风散寒、温经通络的中药外洗配方，有效预防产后洗头引起头风、头疼的中草药配方。

一种治疗内分泌失调型失眠的中药

本发明公开了中医药技术领域，特别涉及一种治疗内分泌失调型失眠的中药。该治疗内分泌失调型失眠的中药包括以下原料：红花，当归，川芎，龙眼肉，鸡血藤，益母草，赤芍，夏枯草，麦瓶草，合欢皮，素馨花，石见穿，紫苏梗，白仙茅，木耳，龙齿，梵天花根，山茱萸，陈皮，海南茄，豆腐渣果。本发明采用的药材相辅相成，根据中医理论组方，按照一定的重量份数配制而成对治疗内分泌失调所引起的失眠具有显著的疗效，而且其安全可靠，具有直达病灶，活血行气，滋补肝肾，调经止痛，理气安神等作用，本发明药物标本兼治，无毒副作用，疗效快，不复发。

疏通经络和微循环系统的组合物及其制备方法和用途

本发明公开了疏通经络和微循环系统的组合物及其制备方法和用途，由以下重量份数的成分组成：葛根1～5份、薤白1～5份、枳椇子1～5份、沙棘1～5份、桃仁1～5份、决明子1～5份、紫苏1～5份、山药1～5份、山楂1～5份。本发明经过大量实践证明，具有疏通经络和微循环系统，直至五脏六腑的作用。

A kind of Chinese medicinal herb solid beverage of quick-acting fat melting lipid-loweringings and preparation method thereof

本发明公开了一种速效溶脂降脂的中草药固体饮料及其制备方法，所述速效溶脂降脂的中草药固体饮料的原料包括纳豆、代代花、葛根、薤白、枳椇子、沙棘、桃仁、决明子、紫苏、山药、山楂、蝮蛇。制备时，将处方中的中药材经筛选并用有机溶液进行科学提取其中的有效成分，将提取的干燥物制成粉状，与剩余的提取后并干燥后的药材残渣细粉混合后制成粉状混合物，并装入规定量无毒合格外包装袋中，封口。本发明经临床验证，其降脂总有效率可达92%，且具有速效之特点，药食同源，无毒无害，标本兼治，服务方便，值得广泛推广。

Herbal pharmaceutical composition for regenerative agent of cartilaginous tissue and treatment of osteoarthritis

본 발명은 연골 재생 및 골관절염 치료용 생약 조성물에 관한 것으로서, 보다 상세하게는 강활, 인진 및 소엽을 포함하는 연골 재생 및 골관절염 치료용 조성물에 관한 것이다. The present invention relates to a herbal composition for treating cartilage regeneration and osteoarthritis, and more particularly, to a composition for treating cartilage regeneration and osteoarthritis including vigor, jinjin and lobules. 본 발명의 조성물은 항염증 작용, 소염 진통작용, 관절 조직 분해 효소 억제 작용, 염증 유발 관련 효소 억제 작용, 발부종 억제, 관절활액의 증가 억제 작용, 관절활액의 총단백질 증가 억제 등의 치료 효능이 있어 연골 재생 및 골관절염 치료제로 이용가능하다. The composition of the present invention has an anti-inflammatory effect, anti-inflammatory analgesic effect, inhibitory effect on articular tissue degrading enzymes, inhibitory effect on inflammation-induced enzymes, inhibition of foot edema, inhibition of increase in joint synovial fluid, inhibition of total protein increase in joint synovial fluid It can be used to treat cartilage regeneration and osteoarthritis. 강활 추출물, 인진 추출물, 소엽 추출물, 프로테오글리칸, 프로스타글란딘, MMP-9, COX-2, 연골 재생제, 골관절염. Active extract, human extract, leaflet extract, proteoglycan, prostaglandin, MMP-9, COX-2, cartilage regenerant, osteoarthritis.

Cosmetic and pharmaceutical compositin comprising sasa quelpaertensis extract and urea

본 발명은 천연 소재를 포함하는 화장료 및 약학적 조성물에 관한 것으로, 보다 상세하게는 조릿대 추출물 및 우레아를 포함하는 혼합 조성물을 유효성분으로 함유함으로써 항염 효과, 피부 보습 효과, 피부 장벽 강화 효과 및 아토피 개선 효과가 우수하므로 피부질환의 예방, 개선 및 치료용으로 유용하게 이용할 수 있는 화장료 및 약학적 조성물을 제공한다. The present invention relates to a cosmetic and pharmaceutical composition comprising a natural material, and more particularly, by containing a mixed composition containing the extract and urea as an active ingredient, anti-inflammatory effect, skin moisturizing effect, skin barrier strengthening effect and atopy improvement Since the effect is excellent, it provides cosmetic and pharmaceutical compositions that can be usefully used for the prevention, improvement and treatment of skin diseases.

Process for preparing omeprazole preparation

The omeprazole preparation is prepared by mixing omeprazole with oil, remixing with metal chelating polysaccharide to obtain emulsion, adding metallic salt solution into the emusion to obtain a solidified polysaccharide granule, and then freeze-drying and coating it with enteric coating to obtain the final product.

Traditional Chinese medicine preparation for treating chronic cough and preparing method thereof

本发明提供了一种用于治疗慢性咳嗽的中药制剂，中药制剂的原料药包括炙麻黄、杏仁、生石膏、生甘草、竹茹、枳实、法半夏、生栀子、黄芩、桔梗、苏子、桑白皮、地骨皮、粳米、葶苈子、芦根、麦门冬、浙贝母、茯苓、瓜蒌、前胡、白前、炙百部、鱼腥草、陈皮、金银花、青黛、化橘红和蒲公英。本发明中药制剂在中医理论的指导下，根据大量的临床观察，对证型、临床表现及治疗预后等进行综合分析，组方用药，不仅具有止咳、平喘、化痰功效，并且通过动物实验验证，以及通过了中药安全性评价，证实本发明中药制剂具有很好的治疗慢性咳嗽的效果。

A kind of composition and preparation method thereof of health treatment hypertension

本发明涉及一种健康治疗高血压的组合物，包括以下重量份的原料：苦丁茶1‑4份、罗布麻2‑5份、酸枣仁3‑6份、黄芪1‑4份、野菊花1‑4份、紫苏4‑7份、葛根4‑7份、夏枯草2‑5份、杜仲5‑10份、山豆根1‑4份、白芍2‑5份、甘草6‑11份、玉米须3‑6份、绞股蓝4‑8份、钩藤1‑4份、珍珠母3‑6份、丹参1‑4份、代赭石2‑5份、桑椹0.5‑1份、芹菜3‑6份、苹果1‑4份、荸荠3‑6份、番茄1‑4份。本发明的组合物的原料绿色环保，将多种中药材与食物进行科学合理的配伍，能有效降低血压，并且对高血压有良好的治疗效果，无副作用，适合长期使用。

Menyanthes-root-flavor lansium parasiticum jam and preparation method thereof

本发明公开了一种睡菜根风味龙贡果酱及制作方法，以睡菜根、龙贡为原料，同时添加密蒙花、芦根，制作出一种睡菜根风味龙贡果酱。其充分利用睡菜根、龙贡的营养价值，与中药相互配伍，协同增效，具有养肝明目的功效。发明中，采用纤维素酶、半纤维素酶与蛋白酶对原料睡菜根进行了联合酶解，有效去除了睡菜根青草味；对龙贡进行了甜酒曲初发酵，为成品添加了醇香味，制得的成品味道酸甜，清爽可口，营养丰富，且保健功能突出，贮存方便，长期食用可明显改善因用眼过度导致的视物模糊人群的不适。其制作工艺简单，易于实现，市场广阔，能够进行批量生产。

Drug for treating cough and preparation method thereof

本发明公开了一种治疗咳嗽的药物及其制备方法，其主要是由防风、紫苏叶、荆芥、桔梗、紫菀、百部、白前按一定重量配比制备而成，本发明药物具有温润肺气，燥湿化痰，泻肺降气，理气健脾，和中缓急，祛风胜湿的功能，用于止咳见效快，疗效好，不复发。

A kind of injection and preparation method thereof containing fructose

本发明公开了一种含果糖的注射液及其制备方法，包括以下重量份的原料：果糖50～80份，醋酸钠2.0～3.0份，板蓝根1.5～2.5份，桑姜1.6～2.0份，金银花2.2～3.5份，黄岑2.2～3.5份。本发明通过加入果糖，保证了注射液不仅具有很好的消炎作用，还给患者机体注入能量，这样有助于感冒患者快速恢复身体的机能；本发明操作方便，制备简单。

Compositions for dandruff and scalp care containing oriental herbal complex extracts

본 발명은 한방 복합추출물을 유효성분으로 포함하는 비듬 및 두피 케어용 조성물에 관한 것으로서, 어성초, 자소엽, 녹차, 감초, 마치현, 한련초, 측백, 삼백초, 구아바잎, 하수오, 검은콩, 창포잎, 생강, 소루쟁이, 로즈마리 및 마늘로 이루어진 한방 복합추출물을 유효성분으로 포함하는 것을 특징으로 하는 본 발명의 비듬 및 두피 케어용 조성물은 비듬균의 성장을 억제하고 피지의 증식을 억제하여 비듬제거, 두피 가려움증 개선 및 지루성 피부염의 개선효과가 우수하다. 또한, 본 발명의 한방 복합추출물을 포함하는 비듬 및 두피 케어용 조성물은 두피를 진정 및 연화시키고 피부 염증을 완화하여 두피 건강을 개선하며, 모근 강화를 통해 모발 굵기를 증대시키고, 발모를 촉진하고 탈모를 방지할 수 있다. 따라서, 본 발명의 비듬 및 두피 케어용 조성물은 인체에 부작용이나 독성이 없어 비듬 및 두피 케어용 화장료 및 약학적 조성물로 유용하게 사용될 수 있을 것으로 기대된다. The present invention relates to a composition for dandruff and scalp care comprising an oriental herbal complex extract as an active ingredient. The composition for dandruff and scalp care of the present invention, comprising as an active ingredient an oriental herbal complex extract consisting of ginger, cypress, rosemary and garlic, suppresses the growth of dandruff bacteria and suppresses the proliferation of sebum to remove dandruff, scalp itchiness It is excellent in improvement and improvement of seborrheic dermatitis. In addition, the composition for dandruff and scalp care containing the oriental herbal complex extract of the present invention calms and softens the scalp and relieves skin inflammation to improve scalp health, increases hair thickness by strengthening the hair root, promotes hair growth and hair loss can prevent Therefore, the composition for dandruff and scalp care of the present invention is expected to be usefully used as a cosmetic and pharmaceutical composition for dandruff and scalp care because it has no side effects or toxicity to the human body.

Composition for anti-inflammation comprising extract mixture of corn silk, perilla leaf and grape stem as effective component

본 발명은 옥수수 수염, 들깻잎 및 포도가지의 혼합 추출물을 유효성분으로 함유하는 항염용 조성물에 관한 것으로, 본 발명의 유효성분인 옥수수 수염, 들깻잎 및 포도가지의 혼합 추출물은 이들을 단독으로 사용하는 것에 비해 피부염에 의해 유도된 NO 생성을 현저하게 감소시키며, 피부염에 의한 가려움 및 피부 두께 등을 감소시키는 효과가 있다. 따라서 본 발명은 피부염의 예방, 개선 또는 치료에 효과가 있으므로, 피부염 치료제 뿐만 아니라 피부염 환자용 건강기능식품 또는 아토피 피부용 화장품 개발에 효과적으로 이용될 수 있다. The present invention relates to a composition for anti-inflammation comprising a mixed extract of corn ale, perilla leaves and grape leaves as an active ingredient, and a mixed extract of corn ale, perilla leaves and grape leaves, which are effective ingredients of the present invention, The NO production induced by dermatitis is markedly reduced, and there is an effect of reducing the itching caused by dermatitis and skin thickness and the like. Therefore, the present invention is effective for the prevention, improvement or treatment of dermatitis, so that it can be effectively used for the development of a health functional food for atopic dermatitis patients or a cosmetic for atopic skin as well as a dermatitis therapeutic agent.

A kind of diet therapy formula and preparation method thereof for treating bronchitis

本发明涉及一种治疗支气管炎的食疗配方及其制备方法，所述食疗配方包括A膏和B膏，A膏采用党参、黄芪、白术、防风、熟地、萸肉、山药、天冬、麦冬、五味子、附块、桂枝、茯苓、甘草、麻黄、苏子、干姜、细辛、益智仁、砂仁、陈皮、沉香、银杏、胡桃肉、晒参、蛤蚧、驴皮胶为原料并进行适合重量配比，B膏采用瓜蒌、百合、杏仁、远志、苏子、芥子、川贝、桑白皮、葶苈子、菜菔子、麦冬、黑虎耳草、蛤蚧、冬虫夏草、大枣、黑糖、饴糖、蜂蜜、梨汁为原料并进行适合重量配比，白天食用A膏，晚上食用B膏，共同起到温肾纳气、健脾化湿、益肺固卫、散寒涤饮的功效，对于急性支气管炎、慢性支气管炎、慢性咽喉炎、哮喘、支气管扩张并肺气肿等症疗效显著。

Compound Chinese herbal medicine preparation, preparation method and application

本发明公开了一种复方中草药药剂、制备方法和应用，所述复方中草药药剂的配方包括：按重量称取3‑6份白茯苓、14‑20份甘草、1.5‑3.5份桑叶、1.5‑3.5份紫苏、1.5‑3.5份蒲公英、1.5‑3.5份马齿苋和0.5‑1.5份艾叶；还包括以下步骤，(1)按配方重量比取桑叶、紫苏、蒲公英、马齿苋和艾叶混合，得到煎煮草药；(2)将煎煮草药放入煎锅内，加入煎煮草药8‑50倍重量的水，浸泡10‑120分钟后，加入水1/10‑2/5倍重量的带孔煮石进行煎煮，煎煮后得到煎剂；(3)按配方重量比往煎剂中加入白茯苓和甘草，超声处理20‑60分钟，再加入煎剂重量3‑10％的甘油，加工处理后得到复方中草药药剂。本发明的药剂用料简单，价格适中，能清洁、杀菌和保护皮肤，饮用还能清热解毒。

Shell powder nano antibacterial foot bath effervescent tablet and preparation method thereof

本发明公开了一种贝壳粉纳米抗菌足浴泡腾片及其制备方法，泡腾片的成分及其重量份为：纳米贝壳粉80‑98份、中药抗菌活性组分2‑20份、PEG6000 5‑10份、酒石酸钠14‑18份、碳酸氢钠20‑30份、聚维酮0.02‑0.04份、水0.8‑1.2份。泡腾片的制备方法为：将贝壳用酸浸泡，洗净，烘干，研磨得粗贝壳粉；然后粉碎得纳米贝壳粉；将中药抗菌活性组分的原料粉碎，煎煮，过滤，浓缩，粉碎；将PEG6000熔融，加入碳酸氢钠，搅拌均匀，粉碎，加入剩余原料，打均匀，压片得足浴泡腾片。本发明泡腾片安全无毒、抗菌谱广、抗菌效率高、稳定性好；其制备方法能解决粘冲问题，片剂成型率高，降低生产成本。

It is a kind of for treating the Chinese medicine composition of childhood asthma

本发明提供了一种用于治疗儿童哮喘的中药组合物，它由如下重量份数的原料提取加辅料制备得到：原料为黄芪10‑15份、生白术8‑10份、防风5‑8份、太子参10‑15份、茯苓8‑10份、炙甘草3‑5份、陈皮3‑5份、制半夏3‑5份、山药8‑10份、橘络3‑6份、南沙参8‑10份、北沙参8‑10份、天冬8‑10份、麦冬8‑10份、灵芝8‑10份、五味子3‑5份、生地黄8‑10份、女贞子8‑10份、蝉蜕3‑6份等，本发明补益肺脾肾为主，兼顾宣肺化痰平喘，能治疗儿童哮喘，并公开了制备方法和用途。

PHARMACEUTICAL COMPOSITION BASED ON VEGETABLE COMPONENTS FOR TREATMENT OF HIV / AIDS-PATIENTS

2003110940 А ко РОССИЙСКАЯ ФЕДЕРАЦИЯ ФЕДЕРАЛЬНАЯ СЛУЖБА (19) (13) 77 © (11) = 0 и. х (51) МК’ А 64 К 35/76 27 7 2 7 р 7% Ре # т, 7 р # % ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12 ИЗВЕЩЕНИЯ К ЗАЯВКЕ Н А ИЗОБРЕТЕНИЕ (21), (22) Заявка: 2003110940/15, 17.04.2003 (30) Конвенционный приоритет: 31.07.2002 ЦЗ 10/208,050 (43) Дата публикации заявки: 27.10.2004 Адрес для переписки: 125040, Москва, Ленинградский пр-т, 23, "Транстехнология", Н.И.Золотых (71) Заявитель(и): ВУ Тзу-Шенг (Т\М/) (72) Автор(ы): ВУ Тзу-Шенг (Т\М\/) (74) Патентный поверенный: Золотых Наталья Ивановна (54) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ НА ЛЕЧЕНИЯ ВИЧ/СПИД-БОЛЬНЫХ ОСНОВЕ РАСТИТЕЛЬНЫХ КОМПОНЕНТОВ ДЛЯ ГАЗА - Признание заявок на изобретение отозванными в связи с непредставлением в установленный срок ходатайства о проведении экспертизы заявки по существу Дата отзыва заявки: 18.05.2006 Извещение опубликовано: 10.07.2006 БИ: 19/2006 Страница: 1 па д0ФУб0гг$00Сс А"

Acne solution

A composition for the treatment of acne includes hydrolyzed psoralea corylifolia, containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In various implementations, the composition is a water-based acne gel or a water-based cleanser. In a specific implementation, a composition includes Bakutrol(TM), which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid, benzoyl peroxide, tretinoin, retinol, tazarotene, or an antibiotic, or a combination of these. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

Acne solution

A composition for the treatment of acne includes hydrolyzed psoralea corylifolia , containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In various implementations, the composition is a water-based acne gel or a water-based cleanser. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid, benzoyl peroxide, tretinoin, retinol, tazarotene, or an antibiotic, or a combination of these. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

Acne solution

A composition for the treatment of acne includes hydrolyzed Psoralea Corylifolia , containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

Anti-acne formulation

A composition for the treatment of acne includes hydrolyzed Psoralea Corylifolia, containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

Acne solution

用于治疗痤疮的组合物，其包括溶解在水基溶液中的含有补骨脂酚组分的经水解的补骨脂。所述化合物用于局部施用在皮肤上。在一种具体实施方式中，组合物是水基痤疮凝胶。在一种具体实施方式中，组合物包括含有补骨脂酚的Bakutrol(TM)、和没药醇。组合物可包括聚山梨醇酯表面活性剂。在多种实施方式中，将这些成分与包括例如水杨酸的其它活性成分组合。制备所述组合物的方法允许在溶液中稳定化Bakutrol。

Golden flower wine formula for preventing diabetes and preparation method thereof

本发明公布了一种预防糖尿病的金花酒配方及其制备方法，包括以下质量份数的原料：高粱90～110份、小麦20～30份、茯砖茶8～12份、桑叶2～4份、甘草根1～3份、番石榴叶4～6份、紫苏籽3～5份、熟地黄4～6份、麦冬6～8份、苍术5～7份、莲藕10～12份、翻白草3～5份、黑翅土白蚁1～3份。本发明的目的是提供一种预防糖尿病的金花酒配方及其制备方法，长期适量饮用，可改善身体机能，提高免疫能力，能够对糖尿病起到早期预防和治疗的作用。

Herbal Composition for Preventing or Treating Respiratory Disease

본 발명은 개자(Brassicae Semen) 추출물, 사삼(Adenophorae Radix) 추출물, 인동(Lonicerae Folium) 추출물, 및 자소자(Perillae Semen) 추출물로 이루어진 군으로부터 선택되는 2종 이상의 혼합추출물을 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 약제학적 조성물 및 호흡기 질환의 예방 또는 개선용 식품 조성물에 관한 것이다. 본 발명의 개자, 사삼, 인동 및 자소자의 혼합 추출물을 포함하는 조성물은 호흡기 질환의 예방 및 증상을 개선하는 효과가 있고, 폐조직의 손상을 회복할 뿐만 아니라 미세먼지 등 염증유발 물질에 의해 유도되는 염증 및 노화 작용을 억제하며, 항산화 효과가 뛰어나다. 특히 본 발명의 조성물은 텔로미어의 길이를 연장하는 텔로머레이즈의 발현을 증가시킴으로써 종래의 증상 완화제와 달리 미세먼지에 의해 유도되는 퇴행성 호흡기 질환을 근본적으로 치료할 수 있을 것으로 기대된다.

A kind of production method for treating pig parasite and bacterial dermatosis product

本发明公开了一种治疗猪寄生虫与细菌性皮肤病产品的生产方法，将双岐杆菌、乳酸菌、芽孢菌、酵母菌等益生菌及其代谢产物与中草药发酵产物、表皮细胞促生因子的一种或几种按一定比例混合而成。通过上述方式，本发明提供的治疗猪寄生虫与细菌性皮肤病产品的生产方法，该产品可有效治疗猪寄生虫与细菌性皮肤病，恢复猪表皮健康后调节猪体表微生态平衡，在于减少或杜绝动物养殖过程中由于患寄生虫性及细菌性皮肤病使用或皮下注射抗生素药物及驱虫药物，有效地预防和控制猪皮肤病，减少经济损失，降低养殖成本，为生产绿色、无残留的动物制品提供技术及产品支持。

A kind of Chinese medicine composition and method for treating allergic rhinitis

本发明公开了一种可治疗过敏性鼻炎的中药组合物及方法，组合物由以下质量份的原料药组成：白芷2‑5份、藿香2‑5份、肉桂1‑3份、丁香1‑4份、薄荷1‑4份、紫苏叶1‑4份、佩兰2‑5份、白豆蔻1‑3份。上述中药组合物的制备方法为：将相应质量份的原料药分别磨成粗粉，过18目筛，混匀后每10g包裹在一个布袋中备用；现配现用。本发明配方既能清暑化浊、醒脾化湿、芳香行气，又能通鼻宣窍、消肿排脓，尤其适用于治疗因过敏性鼻炎引起的鼻痒、鼻塞流涕、打喷嚏等症状。

Traditional Chinese medicinal preparation for treating chronic urticaria

本发明公开了一种治疗慢性荨麻疹的中药制剂，属于中药领域。其是由下述重量份的原料药制成：荆芥10、皂角刺12、土荆皮10、徐长卿10、葛根8、紫苏子6、大腹皮6、蜂房8、秦艽6、金荞麦8、青黛8、紫花地丁6、降香5、亚麻子8、太子参10、上茯苓6、龙眼肉10、鸡血藤8、淡竹叶8、玉米须6、丝瓜络10。本发明采用天然中药为原料，疗效确切且无毒副作用，能有效治愈慢性荨麻疹且不易复发，有效率达98％。

A kind of composition for preventing and treating fish sporidiosis

本发明涉及一种防治鱼类孢子虫病的组合物，其特征在于由以下重量份的原料制成：青蒿6～10份、苦楝皮6～10份、黄芩10～18份、南瓜子8`12份、白鲜皮3～8份、鱼腥草3～8份、板蓝根10～18份、紫苏叶10～18份、芦根6～10份。本发明具有较好的抗病作用，能有效的防治鱼类孢子虫病，降低因鱼类孢子虫病死亡，无毒副作用以及药物残留，生产成本较低，使用方便。

Traditional Chinese medicine extract composition for improving immunity, preparation method thereof and application thereof in preparation of medicine for improving immunity

提高免疫力的中药提取物组合物、其制备方法及其在制备提高免疫力药物中的应用原料药质量比：太子参：茯苓：麦冬：铁皮石斛：佛手：薏苡仁：白术：紫苏叶：枳壳=6：6：3：2：2：6：6：3：2。紫苏叶水蒸气蒸馏提取挥发油；紫苏叶药渣与其余原料药混合后加水煎煮，滤取水煎液；水煎液浓缩至相对密度1.10‑1.15；浓缩液与紫苏叶挥发油混匀即得。本发明的提高免疫力的中药提取物组合物是缓解化疗后不良反应提高免疫力的中药复方提取物组合物。能够明显提高免疫力，缓解化疗后不良反应。本发明对免疫抑制状态下的机体确有提高免疫功能的效果，与市面同类型产品相比较，效应更佳，差异具有统计学意义。

Composition for anti-inflammatory activity and regenerative effect of cartilaginous tissue

A composition is provided to have anti-inflammatory function, analgesic activity, articulation decomposing enzyme inhibition activity, inflammation inducing related enzyme inhibition activity and foot edema, thereby being helpful to cartilaginous tissue regeneration and articulation health. The composition for regenerating cartilaginous tissue and treating osteoarthritis comprises an extract prepared by extracting a mixture consisting of 3-30 parts by weight of Artemisia capillaris Thunberg, 3-30 parts by weight of Pueraria lobata Ohwil and 4-40 parts by weight of Perilla frutescens var. acuta with a solvent selected from the group consisting of water, C1-5 alcohols and mixtures thereof. The composition decreases the amount of proteoglycan, prostaglandin, matrix metalloprotease or cyclooxygenase in blood.

A kind of Chinese medicine and preparation method for the treatment of qi stagnation and blood stasis type chronic hepatitis B

本发明提供了一种治疗气滞血瘀型慢性乙型肝炎的中药及制备方法，中药各原料药材包括：火炭母草、苦荞头、常春藤、五指毛桃根、穿破石、素馨花、娑罗子、佛手花、枸橘、紫苏梗、玳玳花、橘核、土牛膝、苏木、牛马藤、麦饭石、芸薹子、昆布、斑叶兰和天浆壳。本发明的有益效果：本发明中药，根据中医辨证施治原则，对气滞血瘀型慢性乙型肝炎针对性强，有确切疗效，见效快，毒副作用小且复发率低。

Anti-inflammatory composition comprising phyto-extract mixture and composition for treatment of inflammatory diseases comprising the same

본 발명은 식물의 추출 복합물을 포함하는 항염 조성물 및 염증성 질환 치료용 조성물에 관한 것으로, 보다 상세하게는 축엽자소 추출물 및 백출 추출물을 포함하는 식물의 추출 복합물을 포함하는 항염 조성물; 이의 제조방법; 및 상기 추출 복합물을 포함하는 염증성 질환 치료용 약학적 조성물에 관한 것이다. The present invention relates to an anti-inflammatory composition comprising an extract compound of a plant and a composition for treating an inflammatory disease, and more particularly, to a anti-inflammatory composition comprising an extract compound of a plant containing an extract of axon leaf and an extract of a leaf; A method for producing the same; And a pharmaceutical composition for the treatment of inflammatory diseases comprising the above-mentioned extraction complex.

Application of Miao medicine Liaoshi Huafeng Dan in preparing medicine for preventing and treating melanoma

本发明公开了苗药廖氏化风丹在制备防治黑色素瘤药物中的应用，通过在体外运用黑色素瘤细胞WM35、WM239检测发现，廖氏化风丹具有显著的抑制黑色素瘤作用，并通过流式细胞检测其在细胞周期方面的作用，结果表明廖氏化风丹对黑色素瘤细胞周期影响显著，并且药物浓度越高，其阻滞越明显，可作为防治黑色素瘤制剂，制备成药剂学上允许的口服液、注射剂、片剂、胶囊剂、滴丸剂等。

Composition for activating protein L-isoaspartate methyltransferase

Traditional Chinese medicine instant tea for treating gastrectasia and preparation method thereof

本发明公开了一种治疗胃胀的中药速溶茶及其制备方法，本发明以以下重量份的原料浸提：白芷5-8、柴胡8-12、防风8-12、苏子5-8、枳实2-4、砂仁8-12、焦白术10-15、苍术8-12、焦神曲8-12、炒麦芽8-12、炒山楂8-12、鸡内金10-15、人参3-5、龙眼肉8-12、山药10-15以及绿茶100-150，将所得浸提液真空浓缩，添加适量麦芽糖醇进行调配，然后进行喷雾干燥，即得所述治疗胃胀的中药速溶茶。

A kind of tasty and refreshing sugar of pre- antiplaque and preparation method thereof

本发明公开了一种预防牙菌斑清口糖，其原料按重量份包括：山梨糖醇30‑40份、赤藓糖醇15‑25份、魔芋粉1.3‑1.5份、硬脂酸钠0.5‑1份、水苏糖0.6‑0.9份、抗性糊精0.5‑0.8份、水果粉末香精0.3‑0.6份、赤藓红0.3‑0.5份、营养剂0.1‑0.2份。本发明还公开了上述预防牙菌斑清口糖的制备方法。本发明的清口糖能清新口气，具有清凉感，同时具有预防牙菌斑的效果。

Traditional Chinese medicine for treating sinobronchiales syndrome

本发明公开了一种治疗鼻旁窦支气管综合征的中药，是由中草药栝楼子、天浆壳、白苏子、狗尾花、南天竹子、白前、庵摩勒、白沙糖、天水蚁草、狗屎花、挂兰、海胆、海蜇、肥皂荚、光叶水苏、山梗菜、蒙古扁桃、常山、瓜蒌、山椒根组成。本发明以纯天然的中草药为原料，标本兼治，疗效确切、无毒副作用，不易复发。

Suitable for treating the Chinese prescription of Chronic Obstructive Pulmonary Disease

本发明公开了一种适于治疗慢性阻塞性肺疾病的中药组方，由以下原料组成：当归6～13g，生地10～20g，川芎4～10g，桃仁6～14g，红花6～13g，枳壳4～10g，赤芍6～13g，柴胡3～7g，生甘草4～8g，桔梗3～7g，怀牛膝6～13g，生黄芪20～30g，白芥子6～13g，苏子6～13g，莱菔子6～13g，车前子4～10g，旋覆花8～16g，杏仁6～14g。本发明疗程短且疗效明显，总有效率达到95％。

Chinese medicine composition and preparation method thereof for weight-reducing

本发明公开了一种用于减肥的中药组合物及其制备方法，该组合物由以下重量份的原料组分制成：黄芪15‑22份、苦丁茶10‑20份、人参8‑15份、茯苓11‑20份、绞股蓝9‑19份、决明子13‑22份、榧子15‑25份、紫苏叶8‑18份、夏枯草10‑22份、乌梅11‑21份、甘草7‑11份。本发明药物有效率达97％，见效快、药性缓和，毒副作用小；全方立法缜密、配伍精当，以健脾益气固本，利水消食治标，兼以清热、化瘀，标本兼顾、攻补兼施；用户不仅能体会中医祛邪而不伤正的传统养生之道，真正达到瘦身而不伤正气，亦能达到降脂减肥而心情愉悦的目的；降脂减肥不伤身体，停药后体重不反弹，并预防减肥期间心情抑郁。

A kind of eliminating dampness and expelling toxin fermented beverage and preparation method thereof

一种祛湿排毒发酵饮品及其制备方法，属于保健饮品领域，包括如下重量份数的物质：马齿苋5‑9份、紫苏子4‑9份、白芷3‑7份、甘草5‑9份、青果1‑5份、栀子3‑6份、陈皮5‑11份、荷叶4‑9份、木瓜20‑50份、薏苡仁30‑60份、赤小豆50‑100份、山药20‑40份，甘蔗100‑200份、淀粉酶15‑30份、乳酸菌10‑20份。本发明的优点是：本发明选用的药品全部来自于药食同源的药品，且发酵用的木瓜、山药、薏苡仁和赤小豆均为常见食品，故而本发明食用后不会产生副作用，且选物质组合能够起到祛湿排毒的作用。

Traditional Chinese medicine composition for treating bronchiectasis lung-spleen qi deficiency and phlegm-damp lung blocking syndrome and application thereof

本发明涉及一种治疗支气管扩张症肺脾气虚、痰湿阻肺证的中药方，可有效解决支气管扩张症的治疗用药问题。解决的技术方案是中药方是由重量份的：炙黄芪9‑50份、姜厚朴6‑20份、人参3‑12份、法半夏6‑15份、浙贝母6‑20份、金荞麦15‑50份、薏苡仁6‑50份、蜜紫苏子5‑20份、三七2‑15份、矮地茶15‑40份、桔梗3‑15份组成。本发明治疗支气管扩张症肺脾气虚、痰湿阻肺证的中药方，可在制备治疗支气管扩张症肺脾气虚、痰湿阻肺证的药物中应用。本发明组方科学、合理，中药方具有补肺健脾、燥湿化痰的功效，可有效用于治疗支气管扩张症肺脾气虚、痰湿阻肺证，特别适用于支气管扩张症、中医辨证为肺脾气虚、痰湿阻肺证，是中药上的一大创新，经济和社会效益显著。

Method for extracting perilla oil and ursolic acid from perilla seeds

本发明提供一种用紫苏籽提取紫苏油和熊果酸的方法，经石油醚浸提、过柱等方法获得熊果酸和齐墩果酸晶体。该法能使紫苏充分利用，获得紫苏籽油、熊果酸和齐墩果酸产品，有效降低其生产成本，充分利用了紫苏籽中两种主要活性成份。通过树脂与结晶相结合，减少化学试剂的过度使用，保证了产品的纯天然性，可以安全的提供给食品、化妆品和制药等行业。

Astaxanthin purple perilla soft capsule and preparation method

一种虾青素紫苏软胶囊及制备方法。越来越多的研究显示抗氧化是预防衰老的重要步骤，因为自由基或氧化剂会将细胞和组织分解，影响代谢功能，并会引起不同的健康问题。如果能够消除过多的氧化自由基，对于许多自由基引起的及老化相关疾病都能够预防，例如常见的癌症、动脉硬化、糖尿病、心血管病、关节炎等，这些疾病都被认为与自由基相关。一种虾青素紫苏软胶囊及制备方法，所述的内容物原料的重量份数比：200g的雨生红球藻粉、288g紫苏籽油、15g的蜂蜡，所述的软胶囊皮原料的重量份数比：235g的明胶、117g的甘油、235g的纯化水和11.2g的焦糖色组成,以上所述的内容物和所述的软胶囊皮配比制造出的软胶囊重量为0.5g/粒。本发明应用于医药保健领域。

The non-oily extracts having anti-thrombosis activity extracted from perilla fruescens seed coat and the use thereof

본 발명은 들깨( Perilla fruescens ) 종피 추출물을 유효성분으로 함유하는 항혈전(anti-thrombosis) 조성물에 관한 것으로서, 보다 구체적으로는, 수세 후 냉풍 건조한 비파쇄 및 비가열된 들깨 종자를 95% 에탄올로 10~24시간 실온에서 종피 성분만을 추출하여 조제된 추출물 및 이의 활성 분획물을 유효성분으로 함유하는 항혈전 용도의 조성물에 관한 것이다. 본 발명의 항혈전성 조성물의 유효성분으로서의 비마쇄 및 비가열된 들깨 종자로부터 얻어진 들깨 종피 에탄올 추출물은 본 명세서의 실시예를 통해 증명된 바와 같이, 인간 혈전생성 효소 및 혈전생성인자를 특이적으로 저해하며, 특히, 열 안정성이 우수하고, pH 2의 산성조건 및 혈장 내에서도 상기 활성의 감소가 나타나지 않아, 추출액, 분말, 환, 정 등의 다양한 형태로 가공되어 항혈전성 식품, 건강 기능 식품, 약학 조성물 또는 의약품 첨가제 등의 용도에 적용되기에 매우 유용한 발명이다. The invention perilla (Perilla More particularly, the present invention relates to an anti-thrombosis composition containing an extract of Sephiroth fruescens as an active ingredient. More specifically, it relates to an anti-thrombosis composition comprising a non-disrupted and unheated perilla seed which has been washed with water after being washed with 95% ethanol for 10 to 24 hours at room temperature The present invention relates to a composition for anti-thrombotic use containing an extract prepared by extracting only a seed coat component and an active fraction thereof as an active ingredient. The perilla seed ethanol extract obtained from the non-edible and non-heated perilla seeds as the active ingredient of the antithrombotic composition of the present invention can be produced by a method comprising the step of administering a specific amount of human thrombogenic enzyme and thrombogenic factor In particular, it has excellent thermal stability and does not exhibit a decrease in the activity even in an acidic condition of pH 2 and plasma, and is processed into various forms such as extract, powder, ring, and tablet, It is an extremely useful invention to be applied to the use of pharmaceutical compositions or pharmaceutical additives.

A kind of feed of prevention infectious atrophic rhinitis of pig

本发明涉及一种预防猪传染性萎缩性鼻炎的饲料，其特征在于由以下重量份的原料制成：玉米450～480份、全脂米糠120～140份、豆粕120～150份、鱼粉50～70份、油糠120～140份、沸石粉10～20份、甜菜碱5～10份、大蒜粉5～10份、灵芝3～6份、辛夷10～15份、白芷6～10份、苍耳子5～8份、细辛6～10份、紫苏叶5～8份、穿心莲8～12份、山银花8～12份。本发明具有较好的预防猪传染性萎缩性鼻炎，有助于增强免疫力，促进生长与发育。

Coating for wall surface

本发明提供了一种墙体涂料，通过在硅藻泥基体中均匀混合添加艾草、花粉、熏衣草、洋甘菊、七里香、酸枣仁、远志、合欢皮、冰片、红茶、绿茶、薄荷、香叶天竺葵、猪笼草、白芷、贯众、苍术、辛夷花、藿香、苏叶和金银花粉末，从而使得本发明的墙体涂料具备上述这些草药的功能性，这些草药的功能在墙体涂料中缓慢释放，起到驱蚊杀菌、镇静安神、醒神提神、清热解毒和治疗感冒的作用，促进人体的健康，同时使得室内空气清晰。

A kind of hand-held type multifunctional massage machine for treating knee pain

本发明公开了一种治疗膝盖痛的手持式多功能按摩装置，包括握杆，所述握杆的顶端固定连接有竖杆，所述竖杆的顶端固定连接有缓冲弹簧，并且缓冲弹簧的顶端固定连接有顶板，所述顶板的顶部固定连接有缓冲棉，并且顶板顶部的左侧固定连接有按摩装置，所述顶板顶部的右侧固定连接有竖板，所述竖板的右侧固定连接有按摩头，所述按摩装置包括固定框，所述固定框表面的顶部和底部均滑动连接有滑头，本发明涉及医疗保健技术领域。该手持式多功能按摩装置，达到了多功能按摩的目的，通过不同的按摩元件的设置，给人们带来不同的按摩体验，实用性较强，可以对痛处进行按摩性锤击，同时可以缓解锤击时的力度，给人们带来舒适体验。

Composition for enhancing the production of ppar and/or ppar-associated factor

Attention is focused on a nutritional composition known as having an effect of controlling blood glucose level. This food is administered to rats over a long time and the expression of genes relating to the lipid metabolism in the liver and fat tissues of the animals is analyzed by the real time PCR method. As a result, it is observed that the expression of PPARα gene is promoted by the above-described food and, in its turn, the expression of fatty acid metabolism-related genes (i.e., PPARα target genes) is promoted while the expression of fatty acid synthases is regulated. Moreover, it is confirmed that the above food exerts an effect of promoting the expression of PPARϜ and adiponectin. Thus, it is found out that this food has effects of enhancing the production of PPAR and PPAR-associated factors.

Compositions for enhancing the production of ppar and/or ppar-associated factors

Attention is focused on a nutritional composition known as having an effect of controlling blood glucose level. This food is administered to rats over a long time and the expression of genes relating to the lipid metabolism in the liver and fat tissues of the animals is analyzed by the real time PCR method. As a result, it is observed that the expression of PPAR.alpha. gene is promoted by the above-described food and, in its turn, the expression of fatty acid metabolism-related genes (i.e., PPAR.alpha. target genes) is promoted while the expression of fatty acid synthases is regulated. Moreover, it is confirmed that the above food exerts an effect of promoting the expression of PPAR.gamma. and adiponectin. Thus, it is found out that this food has effects of enhancing the production of PPAR and PPAR-associated factors.

A kind of pill medicine for treating cough and preparation method thereof

本发明属于中药制剂领域，目的是根据中医对咳嗽的认识机理而提供的一种用于治疗咳嗽的丸剂药物，所述药物的各个组分及其质量份比如下：橘红80g、茯苓220g、瓜蒌皮95g、荆芥120g、鲜地黄280g、金银花200g、陈皮100g、桔梗80g、玄参200g、麦冬150g、紫菀95g、苦杏仁（去皮、尖）70g、法半夏80g、石膏380g、炒紫苏子80g、枳实（炒）95g、甘草95g、知母200g、款冬花80g、薄荷油乙醇溶液70g；本发明提供的药物是一个标本兼治的中药组方。

Composition for promoting metabolic digestion and preparation method thereof

本发明属于药品和食品保健技术领域，涉及一种促进代谢消化的组合物及其制备方法，包括：110～280份紫苏籽油、135～270份沙棘籽油、42～85份番茄红素油树脂、10～55份维生素E、13～47份佛手提取物以及1～34份水果提取物；促进代谢消化的组合物中还加入辅料制成胶囊；辅料包括200～360份明胶、170～400份纯化水、50～200份甘油、1～45份蜂蜡、0.5～3.5份红曲红以及0.1～3份二氧化钛。本发明的产品安全无毒，调节促进新陈代谢水平，促进消化吸收，且营养均衡，提高免疫力，加快溃疡愈合，口感清爽，制备方法简单，原料易得，成本低。

A kind of Eczema Creams agent

本发明公开了一种含β‑葡聚糖成分的治疗湿疹、皮炎等皮肤疾病的湿疹乳膏剂，具有杀菌、消炎、保湿及淡化色素等作用，以天然植物来源的原料配方组合而成，用于护肤品、保健用品及医药产品等领域。所述湿疹乳膏剂由以下重量份的原料制成：乳化剂2～6份，天然植物油5～20份，β‑葡聚糖25～35份，马齿苋提取液2～10份，三七总皂苷0.1～2份，纯化水20～80份。